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Abstract
Many accidental deaths have recently occurred in Indiana due to opioid overdose. The
current study sought to assess the association between sociodemographic factors, health
insurance, and successful treatment completion for opioids abusers in Indiana based on
the existing literature gap. In this study, the dependent variables considered were
treatment completion status and opioid abuse. The independent variables included health
insurance coverage and sociodemographic factors of education, marital status,
employment status, race, gender, and age. I measured both dependent and independent
variables as categorical. A cross-sectional and quantitative research approach was used
by analyzing data from the 2017-Treatment Episode Data Set Discharges (TEDS-D)
using the Statistical Package for the Social Sciences (SPSS) version 25.0.Descriptive
statistics, chi-square, bivariate, and multivariate logistic regression were applied to
evaluate the association. Significant findings revealed that individuals in “not in labor
force” were 2.0 times more likely [OR=2.042, 95% CI (1.853, 2.252), p<0.0001],
unemployed were 1.8 times more likely [OR=1.785, 95% CI (1.662, 1.916), p<0.0001],
and part-timers were 1.4 times more likely [OR=1.406, 95% (1.269, 1.557), p<0.0001] to
complete treatment compared to full-time workers. The outcomes showed that compared
to insured, uninsured individuals were less likely [OR=0.704, 95% CI (0.662,
0.749), p<0.0001] to complete treatment. Intervention plans such as increasing screening
among vulnerable populations, mass education, and advocacy for health insurance
coverage could promote positive social change by decreasing opioid-related mortality and
improving treatment outcomes in Indiana.
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Chapter 1: Introduction to the Study
The World Drug Report of 2018 stated that opioid usage was at the highest level
in recorded history and became is a major concern due to increased drug prescription
misuse and the use of illegal opioids. The report found that prescription drug use has
become a significant menace to public health and law enforcement agencies across the
world. It showed that opioids cause the most harm with a mortality rate of 76 % where
drug use disorders were involved (The United Nations Office on Drugs and Crime or
[UNODC], 2018). Substance abuse, including alcohol, illicit drugs, and prescription
drugs, persists and has become a significant health problem worldwide (Chakravarthy et
al, 2013). Nearly 5% of the world's population used an illegal drug in 2010, and estimates
revealed that 27 million individuals (0.6 % of world adult population) are considered
problem drug users (Chakravarthy et al., 2013). Researchers have shown that alcohol
alone claimed the lives of 2.5 million yearly while that heroin, cocaine, and other drugs
were accounted for 0.1 to 0.2 million deaths each year. Substance abuse causes
significant morbidity, while the treatment of drug addiction represents a real social
burden (Chakravarthy et al., 2013). According to UNODC, the total costs for drug abuse
treatment have been estimated to reach between $200-$250 billion, which constitutes
about 0.3-0.4 % of world GDP (Chakravarthy et al., 2013). Researchers found that only
20% of drug users were admitted for treatment of drug dependency in 2010
(Chakravarthy et al., 2013). A report indicated that individuals who used drugs at least
once a year in 2016 were aged 15-64 years old, accounting for 275 million people
or(5.6% of the world population) [UNODC, 2018].
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The use of addictive substances and the upsurge in drug abuse, along with its
underlying health effects, have emerged as one of the prominent public health problems
(Chaturvedi et al., 2009; Gomes et al., 2018). Additionally, over the past decades the use
of medical and nonmedical prescription of opioids has become a growing concern in the
United States (Bolshakova et al., 2018; Gomes et al., 2018; Lowder et al., 2018; McCabe
et al., 2017; Meyer et al., 2014; Oderda et al., 2015; Wisniewski et al., 2008). However,
researchers have indicated a marked decline in the use of medical and nonmedical
opioids’ prescription in recent years (Kolodny et al., 2015). The Centers for Disease
Control and Prevention (CDC) stated that more than 190 million opioid-related
prescriptions were supplied to American citizens in 2017 with wide variation among
states. Despite government restrictions, the use of illicit drugs (e.g., heroin, cocaine) and
other substances legally obtained (e.g., oxycodone, hydrocodone) has risen to an
alarming level in the United States and particularly in Indiana. Because of the abuse,
many thousands of people have overdosed and died. Additionally, statistics from the
National Center for Health Statistics (NCHS) show that more than 70,000 people died in
2017 alone. It is estimated that an average of 130 United States citizens die every day
because of opioid abuse (CDC, 2017). Furthermore, Gomes et al. (2018) noted the
disability-adjusted life-years (DALYs) due to years of life lost (YLL) at over 800,000 for
people under 65 years old in the United States as a result of opioid overdose. Opioid
prescription abuse can lead to overdose, addiction, and substance abuse disorder (Han et
al., 2017; McHugh et al., 2014; Morales et al., 2019).
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In the state of Indiana,74, 000 people have abused opioids in 2017 (Brewer,
2018). About 1,700 Indiana residents died because of overdose (Richard Fairbanks
Foundation, 2018). The populations most affected were individuals aged 25-34 years and
35-44years old, and males were more vulnerable than females (Gomes et al., 2018).
According to the U.S Census Bureau (2018), Indiana State is home to 6,732,219
residents, with 51.86 % female and 48.14% male and racial groups are composed of 54.8
% Whites, 28.9% African Americans, 10.6% Latinos, 3.6% Asians, and 2.1% of Native
Americans, Alaskans, Hawaiians, and Pacific Islanders. Among the populaces, about
30% have earned a bachelor's or higher, and the remainders have a high school degree.
The median household income in Indiana was estimated at $ 47,642. (U.S. Census
Bureau, 2018). While females and males without employment were 47% and 39%,
respectively (U.S. Census Bureau, 2018). The state of Indiana has implemented plans to
counter the problems of opioid abuse and its health consequences, but despite that, the
issue kept growing.
Several researchers at treatment centers have investigated opioid abuse and its
correlations with opioid misuse. A growing body of evidence suggested that
sociodemographic profiles influenced opioid abuse (Farhat et al., 2015; Gul & Sharma,
2017; Lamptey, 2005; Ranjan et al., 2010; Rather et al., 2013; Simoni-Wastila&
Strickler, 2011; Swendsen et al., 2009; Tavares et al., 2004). For instance, researchers
have shown that divorced marital status, unemployment, and place of residence are
significantly related to drug abuse (Tavares et al., 2004). Additional factors highly linked
to drug abuse include being unmarried, having low educational and low occupational
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levels, and living in rural areas (Gul & Sharma, 2017). Ray et al. (2017) found in their
study that respondents aged under 40 years old, and male were strongly correlated with
opioid abuse. Despite these findings and the implementation of many programs targeting
these variables, the problem of opioid abuse continues to amplify.
This cross-sectional and quantitative study design should be conducted to
improve the burden of opioid abuse in Indiana. The purpose of the present study was to
assess the potential relationship between sociodemographic factors, health insurance, and
successful treatment completion for opioids abusers in Indiana. The outcomes of the
study could promote positive social change by expanding health insurance coverage,
improving treatment outcomes, and by reducing morbidity and mortality rates due to
opioid abuse. In the current chapter, I will discuss the purpose, background, nature, and
significance of the study, the problem statement, research questions, and hypotheses. This
chapter will also include the theoretical foundation and conceptual framework used, its
assumptions, and limitations.
Background of the Study
Opioid prescriptions abuse has emerged as a leading public health concern both
globally and nationwide (Bolshakova et al., 2018; McHugh et al., 2014; Oderda et al.,
2015). It has been well documented that the use of medical and nonmedical prescription
of opioids has increased in the United States for many decades (Bolshakova et al., 2018;
Han et al., 2017; McCabe et al., 2017). In 2004, researchers suggested that approximately
2.5 million individuals aged 12 and older had used nonmedical prescription of pain
relievers within the past year (Wisniewski et al., 2008). Other researchers noted that
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nonmedical prescriptions of opioids have surged to 53%and have become accessible for
individuals to use (Tetrault& Butner, 2015). Several researchers also discussed the
upsurge of medical prescription of opioid in recent years. Meyer et al. (2014) reported
large increases in methadone, oxycodone, and hydrocodone prescriptions with 933%,
588%, and 198%, respectively. Furthermore, a survey by Han et al. (2017) indicated that
roughly 92 million adults used prescription opioids within the past year and about 12
million of them abused them. The use of illicit prescription opioids has become more
fatal (Morales et al., 2019).
Opioid prescription abuse is a significant public health dilemma and can lead to
substance abuse disorder and overdose (Bolshakova et al., 2018, and Han et al., 2017;
McCabe et al., 2017). Recently, Kolodny et al. (2015) noted that people needing
addiction treatment because of OPRs rose to a daunting number of 900%. Gomes et al.
(2018) noted that opioid overdose had claimed more than 800,000 lives under 65 years
old in the United States. In another survey, researchers revealed that about 75% of the
total overdose fatalities were due to prescription opioids (Florence et al., 2016). Morales
et al. (2019) estimated the overdose-related mortality in 2017 to reach more than 70,000
people. The burden of opioid abuse continues to grow, despite massive government
spending in healthcare. In Indiana, opioid overdose claimed the lives of over 1700 people
(Richard Fairbanks Foundation, 2018).
According to Meyer et al. (2007), the total medical costs related to prescription
abuse was estimated at $55.7 billion annually. Florence et al. (2016) estimated this figure
to be closer to $78.5 billion. Moreover, researchers found that sociodemographic factors
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were significantly associated with prescription opioid abuse (Farhat et al., 2015; Gul &
Sharma, 2017; Lamptey (2005); Ranjan et al., 2010; Simoni-Wastila& Strickler, 2011;
Swendsen et al., 2009; Tavares et al., 2004). Researchers revealed that younger people
aged 15-24 years and 25-44 years old were the most vulnerable (Gomes et al., 2018).
Despite these studies and the implementation of various recommendations, the epidemic
of prescription opioid abuse continues to grow. There was a limited research on health
insurance coverage and treatment completion for opioids abuse, and this cross-sectional
and quantitative study intended to fill the gap. This study is needed to expand health
insurance coverage and improve treatment outcomes while reducing morbidity and
mortality rates due to opioids abuse in Indiana.
Problem Statement
The upsurge of prescription opioid abuse and its emergence as a leading public
health problem had been well documented (American Health and Drug Benefits or
AHDB, 2015). In 2007, an estimated 5.2 million individuals aged 12 years and older had
been reported to abuse prescription opioids during the past month. About 2.1 million of
them initiated nonmedical prescription of opioids (AHDB, 2015). The use of nonmedical
prescription opioids had also climbed sharply and had shown to be very dangerous
because it could lead to addiction and death (AHDB, 2015). The total costs related to
opioid prescription abuse also soared significantly. Birnbaum et al. (2011) noted that the
total projected U.S. expenditure linked to opioid prescription abuse was $55.7 billion in
2007 including $25.6 billion (46%) for workplace, $25.0 billion (45%) for health care
costs, and $5.1 billion (9%) for criminal justice costs.
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Morbidity and mortality related to opioid prescriptions increased dramatically in
recent years (Miller et al., 2018). During 2014 and 2015, the number of fatalities linked
to drugs accounted for 52,404 deaths nationwide, in which 63.1% involved opioid use
(Seth et al., 2018). People aged 24-45 years old were more vulnerable than other age
groups (Gomes et al., 2018). Some toxicology tests on unknown sudden deaths have
revealed that 86.0% were tested positive to opioid, shifting the mortality rate to 86.0%
from 34.2% (Lowder et al., 2018). Data show that individuals aged 18 to 25 years old are
more vulnerable than other groups (NIDA, 2018). Many efforts had been implemented to
curb the epidemic, but the problem continues to grow unabated. Various studies focused
on sociodemographic factors, but few of them are specifically from Indiana, a state of
6.692 million people. Additionally, previous studies failed to evaluate the recently
implemented strategies, which may play a role in the intensification of this opioid
prescription abuse. There is limited research that evaluated opioid abusers’ health
insurance status associated with their treatment outcomes. Researchers suggested that
individuals with better insurance coverage are more likely to receive specialty substance
abuse treatment than those who are uninsured (Cummings et al., 2014). This crosssectional and quantitative study aimed to assess the association between
sociodemographic factors, health insurance coverage, and treatment completion for
opioids abusers using the Treatment Episode Data Set – Discharges (TEDS-D). The
conclusions of this study could help design policies to expand insurance coverage and to
improve opioid treatment outcomes. This could improve morbidity and mortality rates
due to opioid abuse in Indiana.
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Purpose of the Study
Researchers have found that inappropriate use of physicians’ prescription of pain
relievers, lack of training, and lack of cooperation among federal agencies are among the
main factors that lead to opioid abuse. Additionally, sociodemographic factors play a
significant role in the epidemic. Many efforts have been implemented but failed to curb
this growing public health concern of prescription opioid abuse. This cross-sectional and
quantitative approach aimed to examine the correlation between sociodemographic
factors (age, gender, race, education status, marital status, and employment status), health
insurance coverage, and treatment completion outcomes for opioid abusers in Indiana
using the TEDS-D. The primary dependent variable was “treatment completion” and the
dependent variable was “opioids abuse” or “opiates/synthetics abuse.” The exposure or
predictor variables were sociodemographic factors (age, gender, race, education status,
marital status, and employment status) and health insurance coverage.
Research Questions and Hypotheses
Research Question 1: Is there any association between sociodemographic factors
and opioid abusers among residents in Indiana?
H01: There is no association between sociodemographic factors and opioid
abusers among residents in Indiana.
Ha1: There is an association between sociodemographic factors and opioid
abusers among residents in Indiana
Research Question 2: Is there any association between health insurance coverage
and treatment completion for opioid abusers in Indiana?
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H02: There is no association between health insurance coverage and treatment
completion for opioid abusers in Indiana
Ha2: There is an association between health insurance coverage and treatment
completion for opioid abusers in Indiana
Research Question 3: Is there any association between health insurance coverage
and treatment completion for opioid abusers in Indiana after controlling for
sociodemographic factors?
H03: There is no association between health insurance coverage and treatment
completion for opioid abusers in Indiana after controlling for sociodemographic factors
Ha3: There is an association between health insurance coverage and treatment
completion for opioid abusers in Indiana after controlling for sociodemographic factors
Sociodemographic factors were also adjusted to assess their relationship with
treatment completion when controlling for age, gender, race, marital status, employment,
and education level. The dependent or outcome variables considered in this study were
“treatment completion” and “opioids abuse or opiates/synthetics abuse.” They were both
measured as categorical variables. The independent or predictor variables were
“sociodemographic factors” and health insurance coverage and were both measured as
categorical.
Theoretical Foundation
Social cognitive theory (SCT) seemed the most appropriate in this quantitative
cross-sectional study. SCT was invented by Bandura in 1986 (Glanz et al., 2015). The
theory focused on how cognitive, behavioral, personal, and environmental factors interact
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to determine motivation and behavior (Weaver, 2016). Glanz et al. (2015) noted that SCT
had been applied to understand ways individuals may learn about risky behaviors. The
model had also been used to attain individual and group-level behavioral changes (Glanz
et al., 2015). SCT is an essential public health tool for promoting health and had been
effective in managing addictive behavior such as tobacco and alcohol (Glanz et al.,
2015). SCT describes that human behavior is generally motivated and regulated by the
persisting application of self-influence (Glanz et al., 2015). In Bandura's complete
description of SCT, human behavior is elucidated as a triadic and dynamic model of
causation through which behavior, personal cognitive factors, and socioenvironmental
impacts all interact as reciprocal determinism (Glanz et al., 2015). The self-regulative
mechanism functions using one’s self-monitoring, its determinants, and its effects. Selfregulation also embraces one’s self-efficacy, which can promote personal entity through
its vigorous impact on thought, motivation, and action (Glanz et al., 2015). The proposed
framework had been widely employed to describe the mechanisms by which individuals
learn about risky behaviors. Additionally, the model had been used in the initiation and
the achievement of individual and group-level behavioral goals and had been effective in
community health promotion strategies (Glanz et al., 2015). For instance, the model of
SCT had been applied by Tze et al. (2012) to learn about youths' substance drug abuse
behaviors and to propose school-based programs to help them resist the drug. The SCT
will be applied in the study to help understand how personal behavior and
socioenvironmental interact to influence health.
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Nature of the Study
The most appropriate research design for this secondary data analysis is a crosssectional and quantitative study. The rationale for selecting this design was that data in
the TEDS-D were collected at one point. An advantage of this type of study, as reported
by Sedgwick (2014) is that it allowed the investigator to estimate the prevalence of
behavior, which had the potential to drive resources allocation and planning
interventions. Also, cross-sectional studies are generally quick, easy, and cheap to
conduct, and there will be no missing participants to follow-up because they are
interviewed once by using a questionnaire survey (Sedgwick, 2014). However, care is
needed if diverse enrollees are included at each time point. It might be hard to evaluate if
variations in prevalence reflect a trend or change between different groups of participants
selected from the population being studied (Sedgwick, 2014). The SCT of Bandura will
be the primary guiding principle of this cross-sectional research approach. A quantitative
method will enable the investigator to display data informing about the association
between sociodemographic factors, health insurance, and treatment completion for opioid
abusers in Indiana. In this study, the outcome variables were “treatment completion” and
“Opioid abuse or opiates/ synthetics abuse” and were both categorical. Predictor or
exposure variables were sociodemographic factors and health insurance coverage, and
both were measured on the categorical level. A survey from the 2017 TEDS-D will be
used and descriptive statistics, Chi-square analysis, and multivariate logistic regression
were applied to analyze data.
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Operational Definitions
Agonists: Are medications designed to activate some receptors in the brain (Indian
Health Service [IHS], n.d). There exist full and partial agonists. Heroin, oxycodone,
methadone, hydrocodone, morphine, and opium are examples of full agonists (IHS, n.d).
Whereas buprenorphine is an illustration of partial agonist (IHS, n.d).
Antagonists: Are medications that have the potential to block opioids by attaching
them to the receptors without causing any opioid effects. Naltrexone and naloxone are
good examples of antagonists.
Analog: Medicines that have similar chemical structure with another medicine,
but are not identical (CDC, 2019).
Chronic pain: refers to pain that persists up to 3 months or more and such pain
can be triggered by an event, condition, injury, treatment, or it can be unknown (CDC,
2019).
Drug abuse: refers to illegal use of drugs or prescription drugs intended for other
purposes and not directed by a physician, often in greater amounts, longer than expected,
and most often by someone else’s prescription (CDC, 2019).
Drug addiction: Drug addiction refers to the persistent chronic use of drug
regardless of serious negative socioeconomic and health consequences and is related to
loss of control over drug use (Cami and Farre, 2003).
Drug dependence: refers to constant use of drug, triggering the neurons to be
accustomed to so that they can only function when the drug is present. When the drug is
absent, this can lead to abnormal physiological reactions that can range from mild (in the
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case of caffeine) to potentially life-threatening situations (in the case heroin) (NIDA,
2019].
Fentanyl: Pharmaceutical drug (synthetic opioid) designed to treat severe pain
such as in advanced cancer. The drug is 50 to 100 times more powerful than morphine.
Nonetheless, there exist illegal made fentanyl which can be sold on black markets
generating heroin-like effect to users, but can be dangerous and very fatal (CDC, 2019).
Fentanyl analogue: Fentanyl analogues are drugs manufactured clandestinely and
synthesized to yield similar psychotropic reactions to regular fentanyl, but come with
slightly different molecular structures, making the screening more challenging for the
investigator (Cabrices et al., 2018).
Heroin: Aprohibited and very addictive opioid drug that is processed from
morphine and obtained from some poppy plants (CDC, 2019).
Illicit drugs: The non-medical drugs that remain illegal by law. There are many
drugs, and it includes amphetamine, marijuana/cannabis, cocaine, heroin, other opioids,
and synthetic drugs like illicitly manufactured fentanyl (IMF) and ecstasy (CDC, 2019).
Licit drug: non prohibited drugs and it includes drugs prescribed by a physician
including the recipient’s instruments for whom the drug is intended to, and this also
incorporates drugs used for treatment of a disease and over the counter medicines when
they are used appropriately (Brecher, 2016).
Long-Term residential treatment: Health service that provides care for 24 hours
daily, often in non-hospital setting, and with concerned individuals willing to stay for
treatment for a period between 6 and 12 months (NIDA, 2018).
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Morbidity rate: Morbidity refers to any subjective or objective departure, from a
state of physiological or psychological well-being. It involves disease, injury, and
disability, and focuses on the number of sick people. Sometimes, this can be referred to
the periods of sickness that these individuals experienced, or the length of their sickness
(CDC, 2012).
Mortality rate: this is referred to the measure of the frequency of occurrence of
loss of life in a specified population within a specific time (CDC, 2012).
Narcotic drugs: this term referred to any substance that is intended to relieve pain.
The term is sometimes applied to all prohibited drugs but theoretically, the term is merely
referred to opioids. Now opioid becomes the ideal term to avert confusion (CDC, 2019.).
Nonmedical use: the use of any prescriptions prescribed by a physician,
prescription drugs that are diverted (drugs not intended to another person to use), for any
purpose, in any amounts, or in specified time-period the drug is prescribed (CDC, 2019).
Opioids: refers to a class of medicines that involves prohibited drugs such as
cocaine, heroin, synthetic opioids (e.g., fentanyl,) and pain killers that are available by
medical prescription (e.g. oxycodone, hydrocodone, codeine, morphine, and lots of others
designed to lessen the intensity of body pain. Opioids’ prescriptions are usually safe
when used in short period of time and when the prescription is used as instructed by a
physician. Nonetheless, because such prescriptions trigger euphoria besides their pain
relief effects, they are subjected to abuse and can lead to addiction (CDC, 2019).
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Opioid abuse: the term is generally applied when one’s body tends to adjust its
regular operation or functioning towards routine use of opioid. Some unpleasant
symptoms can appear when the person is no longer using the drug (CDC, 2019).
Opioid overdose: the use of opioids can affect the brain that controls the
respiratory system. As a result of taking greater amount of opioids, this leads overdose,
which can slow down the respiration process, and in some cases can stop it suddenly,
which can lead to death (MedlinePlus, 2019).
Opioid use disorder (OUD): the term refers to usual or abnormal pattern of opioid
use that can trigger body impairment. A person is considered to have OUD after
unsuccessful efforts or attempts to reduce or curb its use, or when the excessive use of the
drugs can result in many social troubles including absenteeism at workplace, school, or
prevent a person to fulfill normal obligations at home. The term “opioid use disorder or
OUD” is ideal term, especially when used with similar definitions, “opioid abuse or
dependence” or “opioid addiction (CDC, 2019).
Prescription diversion: Prescription drug diversion is an illegal channeling of
regulated pharmaceutical substance or drugs from lawful sources to illegal marketplace
(Wood, 2015).
Prescription opioids: People use prescription opioids to treat or overcome
moderate-to-severe pain and these prescriptions are often recommended after surgery or
injury, or they are sometimes intended for serious health conditions such as cancer (CDC,
2017).
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Short-Term residential treatment: the term short-term residential treatment
involves intensive but somewhat short treatment related to a modified 12-step approach.
The conventional residential treatment model entailed a 3- to 6-week inpatient treatment
(hospital-based) which is followed by a prolonged outpatient rehabilitation that
necessitates focus group participation (NIDA, 2018).
Sociodemographic factors: It is referred to a group defined by
its sociological and demographic profile. It looks at the life around individuals’
characteristics such as age, gender, one’s sexuality, race, religion, income, matrimonial
status, birth rate, death rate, average size of family, heritage, level of education, medical
history and so on. It is basically a grouping of people by those characteristics (Stone,
2016).
Substance abuse: refers to the use of psychoactive substance or drugs that can
provoke harm or causes hazardous effects on the affected individuals, including people
who use alcohol and illicit drugs (WHO, 2020).
Substance dependence: the term substance dependence refers to one’s inability to
function without the use of an illegal drug or substance. This state is indicative of body
impairment under the use of illicit substances (APA, 2000).
Substance use disorder refers to a state of brain impairment that causes a person’s
inability to control the use of a lawful or unlawful substance or medicine. Among others
alcohol, marijuana and nicotine are also considered drugs (Mayo Clinic, 2020).
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Treatment intervention: the term treatment intervention refers to the coherent and
accurate conceptualization of health services delivery, and such treatment is used as
planned (Hart, 2009).
Assumptions
In this cross-sectional and quantitative research, it is assumed that substance
abuse is understood and successfully cured when the person involved (user or abuser) is
judged in the context of one’s family unit or in a secure living group. This point of view
is considered vital in the protection of individual from substance abuse, and this
viewpoint is assumed in the study. It is also assumed that behavioral patterns, attitudes,
beliefs, and values in the society are discernable and that participants understand and
share these patterns. Additionally, it is accepted that the recorded responses or answers
in the TEDS-D survey were the most straightforward and honest. Moreover, it is assumed
that participants in this cross-sectional survey understood well the idea of substance
abuse and its underlying consequences like substance abuse disorder (addiction).
Scope and Delimitations
For this survey, the emphasis was put on the various sociodemographic factors
that might be connected to opioid abuse along with health consequences, including
overdose, addiction, and substance use disorder. This survey's sociodemographic factors
are defined as age, gender, race, marital status, education, and employment status. Using
TEDS-D, the variables included in this analysis were sociodemographic factors, health
insurance status, and treatment completion for opioid abusers in Indiana. This study
excluded individuals under 18 years old and all missing cases in the dataset. Only
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Treatment Episode Data Set -Discharges or TEDS-D were employed to carry out this
analysis. It is a national survey instrument that collects subjects' substance abuse
information, including demographics, admissions, and discharges. Information gathered
in the TEDS was accurate, and all states and local jurisdictions receiving federal funding
participate in the survey. The researcher extracted Indiana information from the TEDS
for analysis of the variables of interest. It appeared that such data contain fewer missing
cases making the data more reliable. But the researcher will use multivariate regression
analysis to minimize potential bias from the TEDS.
Limitations
This cross-sectional survey might not be conducted without limitations. Because
of the nature of data collection, information bias might be introduced via participant selfreport. Self-reporting, a widely used approach for gathering data, and requires
participants to respond to the researcher’s questions without any interference. Selfreporting data represents a problem for most research design, including cross-sectional’s
(Althubaiti, 2016). Substance Abuse and Mental Health Services Administration
[SAMHSA] (2019) reported that external factors such as lack of funding could influence
this study's validity. It has been shown that states receiving higher funding tend to admit
many substance abusers for treatment (SAMHSA, 2019). Some states also reported more
admissions for the same person, which means information gathered represented
admissions instead of the patient (SAMHSA, 2019). Nonetheless, some missing data
were recorded in Indiana. Statistical analyses such as multivariate regression will be
applied to minimize external threats.
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Significance of the Study
The relationship between sociodemographic factors, opioids abuse, and the
resulting health consequence of opioid use disorder has been well established (Tavares et
al., 2004; Lamptey (2005); Swendsen et al., 2009; Ranjan et al., 2010; Simoni-Wastila&
Strickler, 2011; Farhat et al., 2015; and Gul & Sharma, 2017). A mountain body of
evidence suggested that prescription opioid abuse can be deadly. Opioid overdoses
claimed over 70,237 people in 2017 alone, and 2/3 of them (47, 600) implicated opioids
(CDC, 2019). Common licit drugs used in opioid overdose mortality include Methadone,
Oxycodone, and Hydrocodone (CDC, 2017). Also, data showed that illegal drugs,
including methamphetamines, fentanyl, and heroin, play a deadly role, too (NIDA, 2019).
The prevalence of fatal opioid overdoses in Indiana claimed 1,104 lives in 2018 (Richard
Fairbanks Foundation, 2018). Individuals aged 18 years old and over were more
vulnerable than any groups (NIDA, 2018). About $ 56 billion were spent yearly in
prescription of opioid misuse or abuse in the U.S (Birnbaum et al., 2011). To date, few
researchers have assessed the association between health insurance and treatment
outcomes. This cross-sectional survey aimed to fill the gap. When the study is completed,
and its recommendations are implemented, it will promote positive social change by
expanding substance users' coverage and improving their treatment outcomes in Indiana.
Additionally, the results of the study will help reduce morbidity and mortality due to
opioid abuse.
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Implications for Positive Social Change
When this cross-sectional study is completed, the outcomes might have several
practical implications for positive social change. The findings could improve healthcare
professionals' knowledge about specific sociodemographic factors contributing to opioid
abuse while increasing opioids abuse screening in clinical settings in Indiana. The results
provide an opportunity for health professionals to target those most vulnerable by raising
awareness. Moreover, the study's completion would enable policymakers to expand
health insurance coverage for substance abusers who are uninsured or underinsured.
Additionally, this research could help facilitate access to treatment centers for drug
abusers. Most importantly, the results can lay the foundation for increased cooperation
among services to tackle the epidemic of prescription opioid abuse and reduce morbidity
and mortality due to opioids.
Summary and Transition
Prescriptions of opioid have become one of the leading public health problems in
the United States and in Indiana. It has been demonstrated that opioid abuse can lead to
fatal overdose and substance abuse disorder. More than 2/3 of individuals who overdose
involve opioids. Evidence also suggested that the total healthcare expenditure due to
opioids were estimated at $ 55 billion annually. Sociodemographic factors have shown to
be linked to opioids abuse. Few studies have been conducted about insurance coverage
and treatment completion for opioid abuse. This study will fill the gap and assess the
correlation between insurance coverage and treatment completion. The outcomes of the
study will help expand coverage for substance abuse and improve the treatment outcomes
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in Indiana. Various intervention plans have been put forth to tackle this growing issue of
opioid abuse. Despite this, the problem continues to grow unabated. The next chapter
(chapter 2) will offer an overview of literature review including (a) scope of prescription
drug abuse, (b) burden of opioid abuse, (c) sociodemographic characteristics and opioid
abuse, (d) health insurance and substance abuse treatment (e) research involving drug
treatment (f) treatment options for opioid abuse (g) existing policies for opioid abuse, and
(h) Summary.
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Chapter 2: Literature Review
Opioid abuse has been a long-standing public health issue that the United States
faces for many years. The societal cost burden of opioid misuse was estimated at $78.5
billion in 2013, and the number continues to grow since (Florence et al., 2016).As of
2013, nearly 2 million individuals reported prescription opioid abuse in the U.S.
(Florence et al., 2016).It is widely recognized that prescription drug abuse or misuse has
been expanding dramatically nationwide during the last decade, and younger adults aged
18 to 25 years remain the most vulnerable. It has been documented that licit prescription
drug such as hydrocodone and oxycodone are the most misused substances among young
adults. The use of prohibited substances including heroin, cocaine, methamphetamine,
and fentanyl has also been shown to be rising over recent decades (Chaturvedi et al.,
2009). Schrager et al. (2014) noted that prescription of opioids has become a growing
public health problem because its abuse or misuse has demonstrated to have a host of
negative health consequences like fatal opioid overdoses.
Similar opioid abuse trend has been seen in Indiana despite spending $43 billion,
and implementating local government restrictions on opioid prescription (Richard
Fairbanks Foundation, 2018). In 2017, the overdose-related fatalities in Indiana were
estimated at 1,700 deaths (Richard Fairbanks Foundation, 2018). In the same year, an
estimated 355 people died from overdose and the bulk of it was attributed to opioids
(Richard Fairbanks Foundation, 2018). The main purpose of this quantitative research
study is to assess the correlation between sociodemographic factors (age, gender, race,
education, employment status, and marital status) and treatment completion for opioids’
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abusers in Indiana. The assessment of the correlation between health insurance status and
successful treatment completion for opioid abuse was unexplored. The current study is
going to fill the gap. In this chapter, I will discuss the search strategy regarding the
sources of interest to develop a literature review and the theoretical
foundation/conceptual framework on which the investigation was built on.
Literature Search Strategy
Numerous databases were searched to perform the literature review in this study.
The search strategy included PubMed, Google, Google Scholar, EBSCO, Academic
Search Premier, ProQuest, Allied Health Source, books, scholarly journals, and Medline.
Some advanced searches have been applied from Walden University library to carry out
the review. Also, published reports and articles from Federal and local governments
websites such as CDC, the Indiana State Health and Marion County health departments,
the National Institute on Drug Abuse (NIDA), as well as the Indiana University School of
Public Health, the Department of Health and Human Services, and the World Health
Organization websites were consulted.
Phrases and search words used in this literature search strategy include
sociodemographic factors, drug abuse, and factors contributing to drug abuse or
addiction. Also, the review has used wording such as mortality, morbidity, opioid abuse,
opioid addiction, dependence, nonmedical substances, medical substances, licit
substances, illicit substances, substance use, drug addiction, substance abuse, association,
correlation, relationship, economic cost, health insurance coverage, treatment completion,
and financial burden. Sometimes, advanced searches have been conducted to yield
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meaningful articles used in this literature review (e.g., sociodemographic factors and
opioid abuse, opioid, and D.P.H). This search strategy has enabled to retrieve relevant
articles from 2004 to current.
Given the scope of articles of interest, the researcher proceeds into the selection of
these sources that meet the search criteria before placing any consideration. This enables
the investigator to move with valuable information from relevant articles for more
credible literature review. The criteria for inclusion in the search are opioid prescription
abuse and sociodemographic factors. This enabled to retrieve only sources focusing on
opioid abuse and its sociodemographic influences. The words opioid misuse, dependence,
and addiction were avoided to prevent confusion in the search outcomes since the study
was only concerned with opioid abuse.
Theoretical Foundation
The theoretical framework in this study will be based on SCT invented by
Bandura in 1986. The SCT will be applied in the survey to help understand how personal
behavior and socioenvironmental interact to influence health. SCT enables one’s
behavior to be largely motivated and regulated by the persistent use of self-influence
(Glanz et al., 2015). In Bandura’s complete description of SCT, human behavior is
elucidated by three constructs such as behavior, personal cognitive, and
socioenvironmental factors. They all interact as reciprocal determinism (Glanz et al.,
2015).
The use of SCT in health issues demands a clear understanding of reciprocal
triadic factors including personal cognitive factors, socioenvironmental, and behavioral
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factors) (Glanz et al., 2015). Personal cognitive refers to the person’s aptitude to selfdirect, self-regulate, and evaluate contextual situations. Glanz et al. (2015) identified
three constructs related to personal cognitive factors. Confidence to get involved in a
certain behavior (self-efficacy) is one construct. The capacity of foreseeing the outcomes
of behavior patterns (outcomes expectations) is another construct. Finally, there is the
skill gained to enact a behavior (knowledge) [Glanz et al., 2015]. Socioenvironmental
determinants refer to physical environmental aspects that promote, allow, or refusal to
engage in a specific behavior. Socioenvironmental aspects involve observational
learning, cultural beliefs to the acceptability of a given behavior (normative beliefs),
social support, and the easing of health behaviors (opportunities and challenges) [Glanz
et al., 2015]. Behavioral determinants or factors impact the health directly. Health
behaviors involve health-enhancing actions that lead to people’s health improvement or
poor actions leading to poor health (Glanz et al., 2015). Behavioral determinants involve
the individuals’ health behavioral abilities (coping skills), their goals for behavior change
(intentions), and the rewards for espousing a healthy behavior (reinforcement) [Glanz et
al., 2015]. Glanz et al. (2015) noted SCT proposed that deterrence of mortality and
morbidity via the increase of healthy behaviors and the lessening of unhealthy ones are
accomplished through the change in these triadic factors (personal cognitive,
socioenvironmental, and behavior) [Glanz et al., 2015].
In SCT, goals are important in changing behavior. Bandura (2004) states that
intentions are considered as goals since performing an action require individuals to
engage in appropriate behavior. Bandura (2004) highlighted the use of goals in SCT.
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When highly valued, goals have the potential to stimulate motivation towards adopting
healthy behavior practices. Setting goals is one of the most appropriate steps in health
behavior change.
Social learning plays an essential factor in individuals’ substance abuse. This has
been demonstrated by Tze et al. (2012) suggesting that students are educated to resist the
drug abuse in a school-based prevention program, leading a substantial reduction of drug
use among them. Tze et al. also noted school-based programs often apply the model
because of the influences of social determinants on adolescents’ development and
adolescents' susceptibility to higher risk behavior of substance abuse. The principle of the
social-cognitive theory is that youths in substance abuse circumstances detect drug-using
peers and start to observe and imitate drug use behaviors (Tze et al., 2012). Evidence
revealed that when an adolescent observes a friend using drugs, he or she may change
their beliefs and attitudes to using a drug (Tze et al., 2012). Similarly, non-drug users
may experience drug use when engaging with individuals who use the drug. Tze et al.
noted that when a group of close friends maintains a positive attitude toward substance
abuse, non-drug users will be less willing to engage in drug use. However, other
researchers refuted such correlation (Tze et al., 2012).
Self-efficacy is another concept of SCT. It is a contextual assessment of a person
confidence to perform a task. Besides, self-efficacy has a crucial role in individuals’
capability to be involved in high-risk behaviors (Tze et al., 2012). According to social
cognitive theory, individuals’ self-beliefs regarding substance abuse influences their
actions (Tze et al., 2012). Moreover, individuals’ capacity to self-direct and self-regulate
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has shown to affect their behaviors. That is, individuals’ self-efficacy to reject substance
abuse are less likely to use drug. The higher the self-efficacy, the lower ability to engage
in drug abuse (Tze et al., 2012). Therefore, self-efficacy has a protective effect on
individuals drug use.
Tze et al. (2012) noted that individuals’ self-efficacy of substance use plays a
significant role in changing them towards drug-using behaviors. Tze et al. cited evidence
from previous studies that showed a strong association between social learning and selfefficacy. It noted that when adolescents are exposed to free cocaine from friends and
know how to inhale it, they will use it (Tze et al., 2012). That is, exposure to drug use by
non-users can influence them and their substance use self-efficacy can rise just by
observing others.
Self-regulative mechanism functions through one’s self-monitoring behavior
including its determinants and its effects. It is the use of one’s behavior that leads to the
interactions between personal standards, environmental circumstances, and affective selfreaction. Besides, self-regulation can embrace the self-efficacy mechanism, which
promotes the use of personal entity through its effect on thought, motivation, and action
(Glanz et al., 2015). This implies that drug abuse can be explained as behavior that is
influenced by the user’s predisposed environment. Thus, personal determinants influence
the behavior of the user.
This SCT has been employed to many disorders, including the use of
psychoactive substances. A study by Bennett et al. (2018) had applied the SCT model to
predict medication compliance in patients suffering from depression in the United States
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in 2016. This cross-sectional research design by Bennett et al. (2018) reported that selfcontrol for taking medication for depression and expectations for taking medicine for
depression were statistically significant with p<0.05. However, the researchers suggested
that the integration of new models was necessary to bolster the SCT constructs (Bennett
et al., 2018). Another study by Biro et al. (2017) used SCT to reduce stress in Hungarian
college students. Expanding knowledge about psychoactive substances use to lessen
stress and developing skills for stress reduction and management approaches are among
the strategies used (Biro et al., 2017).
The theoretical framework has proven to be useful in explaining behaviors related
to drug use and understating personal actions for change. According to Glanz et al.
(2015), SCT explains reasons for individuals to acquire and maintain healthy behaviors.
It has also been used by researchers and practitioners to help them determine factors that
stimulate health behaviors and to promote strategies for behavior change (Glanz et al.,
2015). For instance, da silva and Serra (2004) and Tze et al. (2012) applied the theory to
understand factors that motivate drug use in individuals and promote preventive plans.
However, Bandura’s SCT model has several limitations in the public health field.
The theory assumes that changing environment leads systematically to changes in
individuals, which is not always true (LaMorte, 2018). The theory seems loosely
organized around personal, behavior, and environment, and does not clearly states
whether one determinant has more influence on the others. The theory does not
emphasize on motivation but rather on previous experience. Despite, Bandura’s SCT has
been widely applied in public health initiatives, especially in substance abuse.

29
In Giovazolias & Themeli (2014), researchers noted social cognitive theory selfefficacy and outcome expectancies are two cognitive processes that influence a person’s
behavior. Self-efficacy refers to the evaluation made by the individual relative to one’s
ability to perform an action in a certain situation. And outcome expectancy refers to one’s
beliefs that change in their behaviors may lead to desired outcomes or not (Giovazolias &
Themeli, 2014). The outcome expectancies are acquired through direct experience of a
certain behavior or via observation. Giovazolias & Themeli (2014) noted that the theory
of social cognitive learning is used in substance use to assess outcome expectancies and
have this theory for effective therapeutic interventions.
Heydari et al. (2014) also examined the role of SCT in addiction quitting.
According to the study, the purpose of addiction treatment is to help the client to admit
addiction as a disorder and change in lifestyle can prevent the disease progress
(Heydari et al., 2014). Heydari et al. (2014) found that using SCT can be effective in
assisting individuals quit the addiction.
I used the social cognitive theory (SCT) to help elucidate the outcomes of this
quantitative research. The proposed framework has been widely employed to describe the
mechanisms by which individuals learn about risky behaviors. Additionally, the model
has been used in the initiation and the achievement of individual and group-level
behavioral goals and has been effective in community health promotion strategies (Glanz
et al., 2015). The SCT will be applied in this quantitative cross-sectional study to help
understand how personal behavior and socioenvironmental interact to influence health.
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Conceptual Framework
The framework in this research is based on the philosophical worldviews for their
influence in the research practice and need Creswell (2014). Four frameworks for
research have been identified by Creswell (2014). This includes
postpositivism/positivism, constructivism, transformative, and pragmatism (Creswell,
2014). The term positivism refers to a set of scientific research practices, and the concept
of knowledge, social reality, and of science (Riley, 2007). Positivism assumptions seem
to represent the traditional form of research (Creswell, 2014). Positivism seems the most
appropriate framework for this research. According to Creswell, positivism is seen as an
approach for quantitative research. Positivism is related to various schools of thought,
including empiricism, naturalism, behaviorism, scientism and determinism, and
reductionism. It is reflected as a deterministic philosophy in which causes determine
effects or outcomes (Shah & Al-Bargi, 2013). As a result, the issues investigated in this
framework reflect the importance of identifying and assessing the origins (causes) that
influence the outcomes (Creswell, 2014). This suggests that even though people may or
may not know what causes them to abuse the drug, they would try to find out these
causes and identify corrective actions.
Based on the information described above, the Social Cognitive Theory (SCT)
seemed the most appropriate in this quantitative cross-sectional study. The Theory
focuses on the interaction between cognitive, behavioral, personal, and environmental
factors to establish motivation and behavior (Weaver, 2016). Glanz et al. (2015) noted
that SCT had been applied to understand ways individuals may learn about risky
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behaviors. The model had also been used to attain individual and group-level behavioral
changes (Glanz et al., 2015). SCT is an essential public health tool for promoting health
and had been effective in managing addictive behavior such as tobacco and alcohol
(Glanz et al., 2015). Similarly, SCT will be applied in this research to understand the
sociodemographic factors, health insurance status associated with opioid abuse and
treatment completion in Indiana residents to promote effective intervention plans.
Literature Review
Scope of Prescription Drug Abuse
According to McCabe et al. (2017), medical and nonmedical use of prescription
opioids has been a prominent problem nationwide for many decades. Other researchers
revealed a sharp decline in the use of medical and nonmedical opioids (Kolodny et al.,
2015). The use of medical prescription opioids has demonstrated to be significantly
associated with nonmedical use; Findings revealed that male adolescents have more
likelihood to report both medical and nonmedical use of prescription opioids. Also, the
study suggested that adolescents were more willing to initiate a medical prescription
opioid before they initiated nonmedical prescription opioid (McCabe et al., 2017). The
study by McCabe et al. (2017) noted that the increase in opioids prescription could have
far-reaching opioid-related health consequences such as illegal use, opioid use disorders
or addiction, high rate of emergency department visits, and overdose casualties. Also, a
literature review by Bolshakova et al. (2018) noted that prescriptions of opioid had
increased tremendously both nationally and globally in recent. While opioid can be used
for the treatment of pain in minor and major conditions, prolonged use of it could be
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associated with increased risk of addiction, overdose, and significant psychological
distress (Bolshakova et al., 2018). Similar trends were also found by Kolodny et al.
(2015) and Oderda et al. (2015).
The aim of McCabe et al. (2017) study was to investigate the trends of both
medical and nonmedical use prescription opioids nationwide among high school seniors.
The researchers used the Monitoring the Future (MTF) study for 135 schools to examined
40 independent cohorts, applying random-sampling method. The MTF evaluates a host of
behaviors, attitudes, and beliefs (McCabe et al., 2017). Among the major findings of the
study, the Pearson correlation to assess medical and nonmedical use of prescription
opioids (NUPO) demonstrated higher prevalence in black adolescents than whites’
adolescents with respectively (r = 0.79, P < .001) and (r = 0.65, P < .001). Earlier studies
have revealed that female showed higher medical and NUPO use of prescription opioids,
contradicting the findings of the current study (McCabe et al. 2017). One of the strengths
of the study is that it highlighted the need for clinical opioid screening in adolescents to
tackle the growing drug and mental disorders. A weakness of this cross-sectional study is
self-reporting, which may lead to response distortion. I choose the article because it
highlighted the role of both medical use and NUPO, which represent a damning concern
for American society and for adolescents. The current study goes further to evaluate the
association between sociodemographic factors, health insurance coverage and treatment
completion for opioids abuse.
Wisniewski et al. (2008) also assessed the correlations between medical opioid
prescription, NUPO, and emergency department visits. The purpose of the research was
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to explore the associations between prescription trends for hydrocodone, oxycodone, and
morphine and indicators of nonmedical use and potential consequences in ED visits.
Studies suggested that the trend of medical prescription of opioid analgesics has been
increasing exponentially since the 1990s and that more hydrocodone combined with
acetaminophen has been prescribed than any other drugs (Wisniewski et al., 2008).
Researchers in this study noted that in 2004, about 2.4 million individuals12 years old
and above have initiated nonmedical use of prescription of pain killer during last year,
and evidence showed the use of such prescription drug was correlated with hydrocodone,
codeine, propoxyphene, and oxycodone-containing products (Wisniewski et al., 2008).
However, Meyer et al. (2014) reported a higher rate of 900%, 600%, and about 200% for
methadone, oxycodone, and hydrocodone, respectively. Also, individuals using
prescriptions of opioid analgesics have reached 79.5 million nationwide (Meyer et al.,
2014).
Wisniewski et al. (2008) used a cross-sectional design to analyze four national
databases including the National Hospital Ambulatory Medical Care Survey (NHAMCS),
National Ambulatory Medical Care Survey (NAMCS), The Drug Abuse Warning
Network (DAWN), and the National Survey on Drug Use and Health (NSDUH).
Findings in the study found that medical use and nonmedical use of hydrocodone and
oxycodone and ED visits were correlated and statistically significant yielding a p-value <
0.04. Similarly, male sex, the White race, and age older than 35 were predictors of
hydrocodone and oxycodone prescriptions with p-value < 0.0001 (Wisniewski et al.,
2008). A strength of the study was that the findings might have far-reaching medical
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implications. The outcomes of the study highlighted the need for prescribers to pay close
attention to opioid prescriptions because it may be diverted for nonmedical use. That is,
physicians could limit or restrict opioid prescriptions to their patients to reduce
prescription abuse. A weakness of this cross-sectional study was that secondary analysis
does not establish cause and effect association by its nature. This article is relevant
because of its focus on the relationship between opioid prescribing, nonmedical use, and
emergency department visits. The current secondary data analysis will expand the
knowledge and explore the association between health insurance coverage and treatment
completion for opioids’ abusers.
The United States has been experiencing for decades the problem of prescription
opioid abuse and the underlining consequences of it, including overdose fatalities and
substance abuse disorders continue to grow unabated. In the survey conducted by Han et
al. (2017), researchers evaluated the prevalence of prescription opioid use, misuse, and
use disorders and assessed motivations that lead to the abuse among U.S. adults. The
survey suggested that nearly 91.8 million adults, accounting for 37.8% have used
prescription opioids within the prior year. Among them, 11.5 million individuals (4.7%)
abused them and 1.9 million (0.8%) developed substance use disorders (Han et al., 2017).
Synthetic fentanyl is another form of deadly opioid that users are suddenly facing
(Morales et al., 2019). Han et al. (2017) noted that the risks for abuse or misuse have
complicated opioid prescriptions. The study used a cross-sectional design from the 2015
National Survey on Drug Use and Health (NSDUH) to collect data. A large sample
entailing72 600 adults were selected for NSDUH, and 51 200 showed to complete the
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survey interview. Probability sampling methods have been applied in the study. Major
findings of the survey revealed that among those who abused prescription opioid, 63.4%
cited relief from physical pain as the reason while 47.8% of opioid use disorders cited
pain relief as the main motivation. The conclusions of the research are consistent with
earlier surveys (Han et al., 2017).
Also, among participants who abused or misused prescription opioids, almost 2/3
(59.9%) obtained them without a prescription at least once, and 40.8% got them from a
relative (Han et al., 2017). However, a survey reported that 53% of prescription opioids
for nonmedical use are easily accessible for friends or relative, 15% were bought from a
friend, 21% prescribed by a physician, 3% prescribed by many doctors, 4.6 percent
brought by drug dealer, less than 1% through internet purchased, and 4% via forgery
(Tetrault & Butner, 2015). The findings may have practical implications since they
highlighted the need for implementing policies that target medication sharing, selling,
and diversion. However, the limitation of the study was that it reported a lower response
rate, increasing the potential for nonresponse bias (Han et al., 2017). The article seemed
relevant because it highlighted the significance of opioid prescription abuse, and it
recognized the outcomes of such abuse (e.g., substance abuse disorders) while hinting for
intervention strategies. Similar patterns had been reported by Bolshakova et al. (2019).
Finally, a study by Strain et al. (2019) evaluated the epidemiology, pharmacology, signs,
testing, and detection of opioid use disorder. Strain et al. (2019) noted that opioids are
applied to treat medical conditions and to alleviate pain. Opioids may contain analgesic
and may cause the central nervous system to depress. Opioid prescription abuse can lead

36
to opioid use disorder (OUD) which is linked to high morbidity and mortality (Strain et
al., 2019).
McHugh et al. (2014) noted that prescription drug abuse became a growing health
issue in the nation. In this study, McHugh et al. (2014) aimed to explain a sampling of the
recent research related to prescription drug misuse or abuse ranging from its
epidemiology, correlates, intervention outcomes, and from policy perspectives. The study
suggested that between 1990 and 2000, nearly 3 million initiators of abuse in prescription
occurred annually. The abuse in prescription drug has been increasing in recent years.
McHugh et al. (2014) stated that opioids were the most frequently abused substance and
had contributed substantially to the current crisis.
McHugh et al. (2014) noted that the National Survey on Drug Use and Health
believed that nearly 17 million individuals 12 years old and above had misused
prescriptions nationally in 2012. About 2.1 million individuals align with the
identification of a substance use disorder related to prescription drugs. Also, the number
of adults who abused prescription of opioids went up from approximately 5 to 12.5
million from 1992 to 2012. The paper noted that prescription of opioid use led the pack
of drug abuse disorders, and ranked second after alcohol (McHugh et al., 2014). The
study also noted that prescriptions of opioids abuse were correlated to a range of factors
such as poor performance in school, violence, delinquent behavior, and psychological
disorders (McHugh et al., 2014). The authors of this study used a collection of literature
to review prescription of substance abuse from epidemiology standpoint to public policy
perspectives. The strength of this study was that it highlighted the growing issue of
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prescription of drug abuse, most importantly, the prescription of opioid abuse and its
health consequences and overdose fatalities in the United States. The study revealed
further the need to improve training for prescribers, the prescription monitoring system,
and accessibility to treatment centers (McHugh et al., 2014). One weakness of the study
is that it does not elucidate the approaches used to collect data. The current crosssectional study will look further to assess the realtionship between health insurance
coverage and treatment completion for opioids abuse to design policies to solve this
growing public health problem.
Prescription drug abuse (PDA) is not only emerging as a leading puclic health
problem in the U.S., but also in Indiana. Oderda et al. (2015) noted that prescription drug
abuse or PDA, particularly opioid abuse has been recognized as the fastest-growing threat
to American society and has been classified as an epidemic according to the Centers for
Disease Control and Prevention. This study noted that in 2013 alone, nearly 15.3 million
people (about 6% of the population) reported using drugs for nonmedical reasons, citing
pain relievers as the most common reason. Oderda et al. (2015) noted that between
11,660,000 and 20,660,000 people used illicit drugs once in the year of 2009 (Oderda et
al., 2015). The total prevalence of opioid dependence in North America has been
estimated at 0.30% (Oderda et al., 2015). But, in Indiana, providers prescribed 74.2
opioid prescriptions for every 100 persons in 2017 compared to 58.7 prescriptions across
the United States (National Institute on Drug Abuse, 2019). In 2010, the rate was even
higher, with 107.1 prescriptions of opioids per 100 people (NIDA, 2019).

38
Using a systematic review, the purpose of Oderda et al. (2015) was to analyze
various data and summarize published evidence of the prevalence of prescription opioid
abuse as well as its health consequences and societal costs. In this systematic review, a
Population, Intervention, Comparator, Outcome, and Timeframe format or PICOT was
applied and examined 5,281 citations. The study by Oderda et al. (2015) highlighted the
significance of opioid abuse, the related costs, and health consequences. The researchers
in this review used appropriate approaches because the findings provided an overview of
the prevalence of opioid prescription abuse, the costs, and health consequences.
However, large missing data in the evaluation could impact the validity and reliability of
the findings. If the data were completed, it might lead to different conclusions. However,
this current study will further explore the correlation between health insurance and
treatment completion.
Burden of Opioid Abuse
Opioid prescription abuse and its overdose fatalities are becoming one of the
major public health issues in the nation and particularly in Indiana. Previous studies
found that approximately 1 million disability-adjusted life-years were attributed to opioid
dependence (Gomes et al., 2018). In Gomes et al. (2018), the investigators also revealed
that over half of the disability-adjusted life-years are due to years of life lost or YLL. In
a cross-sectional design study, Gomes et al. (2018) investigated the problem of opioidrelated mortality throughout the nation over time and had noted that prescription opioid
overdose was responsible for 830, 652 YLL among individuals under 65 years old. The
study indicated that the dramatic increase in opioid-related mortality rate could be
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attributable to the recent use of fentanyl and other illicit opioids (Gomes et al., 2018).
Florence et al. (2016) also noted that prescription opioids account for roughly 70% of
drug overdoses fatalities. The survey by Gomes et al. (2018) applied the Centers for
Disease Control and Prevention (CDC) WONDER Online Database to capture mortality
and population estimates by age and gender.
Results from Gomes et al. (2018) indicated that 335, 123 people with opioidrelated mortality in the United States fit the standard selection and noticed a 345%
increase from 33.3 deaths per million population in 2001 to 130.7 deaths per 1,000,000
people in 2016. Males were the most vulnerable, accounting for 67.5% of all opioidrelated mortality, and having a median for age of 40. More alarming, the proportion of
opioid death-related went up from1 in every 255 (0.8%) to 11 in 65 (1.5%) [Gomes et al.,
2018]. Nonetheless, the highest absolute increase was seen among individuals aged 25-34
(from 4.2% in 2001 to 20% in 2016). Individuals aged 14-24 years were ranked second
from 2.9% to 12.4%, respectively, in 2001 and 2016 (Gomes et al., 2018). The findings
revealed that deaths related to opioids abuse accounted for 5.2 YLL per 1000 people in
the United States for the year of 2016, with males being the most affected. Additionally,
those aged 25 to 34 years and 35 to 44 years have the highest prevalence of opioidassociated mortality accounting for 12.9 YLL per 1000 people and 9.9 YLL per 1000
people, respectively (Gomes et al., 2018). These findings are significant because it calls
for interventions targeting the most vulnerable population, as shown above. A limitation
of the study was the definition used in the analysis, which impacts the validity of the
overall outcome. The article is relevant because it discussed the burden of opioid-related
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deaths in the United States, showing opioid prescription abuse and its consequences to be
one of the most pressing issues across the nation. The present study will expand further to
assess the association between health insurance coverage and treatment completion for
opioids abusers.
Also, Kolodny et al. (2015) noted that high mortality rate had been associated
with using opioid pain relievers or OPRs for alleviating pain, which has exacerbated the
ongoing health epidemic. Earlier studies have reported that the prevalence of OPRs use
nationwide has climbed over the last decade. According to the literature, the consumption
of hydrocodone and oxycodone has jumped to 500% from 1999 to 2011. OPR-related
overdose fatalities have reached four times high during the same period. The
unprecedented public health issue has forced the Centers for Disease Control and
Prevention to label it the “worst drug overdose epidemic in U.S history” and to list it
among its top five public health priorities (Kolodny et al., 2015). The upsurge in opioid
consumption has led to a sharp increase in ED room visits for nonmedical OPR abuse or
misuse.
Similarly, the rate of individuals seeking for OPRs addiction treatment rose to
900%. Kolodny et al. (2015) noted that the association between opioid sales, opioidrelated overdose mortality, and opioid addiction treatment has been well-established.
Also, the researchers reported that people who use OPRs switched to illicit opioid
(heroin), and 94% of those reported doing so because it is cheaper to obtain and difficult
for them to access OPRs. Moreover, the prevalence of opioid addiction has increased
significantly, and this has been found to be correlated with a sharp increase in heroin
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morbidity and mortality. Kolodny et al. (2015) noted that Whites aged 20-34 were more
likely to be admitted to rehabilitation centers for addiction treatment, while heroin
overdose mortality for Whites aged 18-44 has climbed to 171%.
In this article, Kolodny et al. (2015) aimed to describe the scope of OPRs use, the
contributing risk factors and evaluate the role of addiction in aggravating the related
mortality and morbidity. The strength of this study was that it recognized opioid
dependence in medical and nonmedical users as the main driver of mortality and
morbidity, contrary to the past where the focus has been made on medical users only. The
weakness of the study is that the sample size and methods used to collect data were not
described, which may affect its validity. This article seemed relevant because it focused
on medical opioids as a public health concern and on its consequences (addiction and
overdose mortality). However, it placed a special emphasis on heroin, aggravating the
situation since it is cheaper to acquire by users. This study will expand knowledge by
emphasizing on health insurance and relationship with treatment completion.
Meyer et al. (2014) described the medical and financial burden of opioid
prescription abuse or misuse by examining 183 articles from the National Ambulatory
Medical Care Survey (NAMCS). The research aimed to conduct a comprehensive review
of the literature to further understand the medical and financial burden of opioid
prescription abuse. The authors noted that the use of nonmedical opioid pain killers has
been surging and has become a pressing public health concern in the U.S. The article
reported that between 2002 and 2007, the rate of nonmedical rose from 11 million
individuals to 12.5 million in the U.S. Meyer et al. (2014) also noted that the prevalence
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of people misusing opiates other than illicit drug (heroin) had surged dramatically from
1997 to 2007 with respectively 7 per 100,000 people to 36 per 100,000 people,
accounting for 414% increase. The burden of opioid abuse has been growing, and Meyer
et al. (2014) have estimated the opioid overdose-related mortality to range from 5,528
deaths in 2002 to 14,800 deaths in 2008. Other published articles have shown higher
figures recently.
The article Meyer et al. (2014) also noted that the White House Budget Office
estimated the medical expenditure for drug abuse to reach $300 billion annually. And in
2007, the estimated costs for misusing opioid were predicted at $55.7 billion (Meyer et
al., 2014). But the article by Florence et al. (2016) estimated the global financial burden
for opioid abuse prescription and addiction at $78.5 billion. Meyer et al. (2014) found
non-opioid pain killing substances stayed steady between 26%–29%, but the proportion
of opioid prescriptions has jumped considerably from 11% in the year of 2000 to 20 % in
2010. The outcomes showed that patients ‘prescription increases with age, accounting for
11.7% for 10–29 years old and 45.7% for 40–59 years of age. A strength of the study is
that it provides insights for clinical implications to target those most affected. A
limitation is that investigators found it difficult to differentiate abuse from misuse and
diversion, which may misguide policymakers in their decision. The current study will
further assess the relationship between sociodemographic factors, health insurance
coverage, and treatment completion.
In a sudden twist of the situation, Morales et al. (2019) noted that fentanyl
mortality from fentanyl-linked fatalities has become the main cause of deaths among U.S
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citizens. The article noted that drug abuse fatality in the United States reached a
staggering number of 70,237 in 2017, accounting for 9% increase compared to the
previous year. The paper noted that a new form of deadly opioid is now taking place,
synthetic drugs such as illicitly manufactured fentanyl (IMF) and its equivalents. Morales
et al. (2019) reported a sharp increase of IMF-related mortality from 3,105 in 2013 to
20,145 deaths (649%) in 2016. The article reported the distribution of IMF deaths in
2016 in Baltimore (Maryland), Providence (Rhode Island), and Boston (Massachusetts)
to be 80.6%, 32.5%, and 35.3%, respectively.
This cross-sectional design by Morales et. (2019) used a sample of 308
participants who have a history of heroin or opioid use within the last six (6) months. The
outcomes of the study showed that willingness for using illegal nonmedical fentanyl have
been reported in 27%. It found that people commencing opioid use without prescription
opioid drugs have the likelihood to prefer fentanyl and 2/3 of the respondents reported an
opioid overdose in the past year. The study found an association between fentanyl and
sociodemographic factors like race and ethnicity (Morales et al., 2019). The findings of
the study could provide clinical implication like screening for fentanyl presence. The
limitation of the study is that it could be misleading because of social desirability bias.
Ray et al. (2017) specifically examined opioid-related overdose trends in Indiana.
The study assessed whether they are associated with variations in synthetic opioid
medications. The authors used data from Marion County Coroner’s Office (MCCO), the
Indiana Scheduled Prescription Electronic Collection and Tracking Program (INSPECT),
the Marion County Forensic Services Agency (MCFSA), and records from the
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Indianapolis Metropolitan Police Department (IMPD). The paper reported the prevalence
of Indiana’s overdose fatalities to be 14.4 per 100,000 residents, ranking the state number
17th nationwide (Ray et al., 2017).
The toxicology test revealed that heroin, morphine, codeine, oxycodone,
hydrocodone, oxymorphone, hydromorphone, and fentanyl were found to be the most
common drugs used. Although hydrocodone and oxycodone remained the most
prescribed opiates in Indiana, the study noted that heroin and fentanyl contributed mostly
to the increase in overdose fatalities. But the National Institute on Drug Abuse reported
that the age-adjusted rate of drug overdose has increased significantly in Indiana from
2016 to 2017 with 24.0 deaths per 100,000 in 2016 to 29.4 deaths per 100,000 in 2017.
Findings Ray et al. (2017) revealed that individuals aged 30-39 and 19-29 years
old have the greatest mortality rate, with 26.6 % and 25.4%, respectively. The results also
found a high proportion rate for male sex (66.7%), White ethnic group (85.3%), and
never married or single (44.8%) [Ray et al., 2017]. A strength of this study is that it
shows that Indiana State has fewer opioid treatment programs or OPTs (14) compared to
other neighboring states like Illinois, Ohio, and Michigan. So, it provides insights for
policy recommendations, including funding, and the creation of additional OPTs to avoid
individuals from traveling a long distance to seek treatment. The study limitation was the
researchers’ reliance on data, which may not be available sometimes as it has been the
case for MCCO data.
In another research by Lowder et al. (2018), the inquirers sought to demonstrate
the severity of undercounting opioid-related overdose fatalities in Indiana. Data
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suggested that Indiana is ranked 17th nationwide when it comes to opioid fatalities.
Opioid overdose mortality in the United States has been well-established. Despite that, a
significant number remained unspecified (Lowder et al., 2018). The study analyzed
toxicology data in MCCO from 2011 to 2016 and examined a sample of 1,238 accidental
poisoning deaths.
The outcomes of the study revealed that 57.7% of accidental overdose deaths
were undetermined and opioids played a role in 34.2%. The results of the investigation
showed that 86.8% of the cases were confirmed positive for opioid. Further, findings
showed opioid-related deaths has doubled from 32.4% to 86.0% (Lowder et al., 2018).
Strikingly, the outcomes demonstrated that fentanyl-related overdose went from 5.4% in
2011 to 51.5%, accounting for 853.7% increase (Lowder et al., 2018). However, 90% of
the overall result involved opioid. Despite the massive spending by federal, state, and
local government to curb the opioid epidemic, the failure to accurately evaluate fatal
opioid-involved overdoses affects the effectiveness of the intervention strategies intended
to address the issue (Lowder et al., 2018). One of the public health recommendations of
the study was the improvement of local surveillance aiming at tackling the epidemic of
opioid. As described by the previous survey, the reliance on population-level data to
predict trends may lead to ecological fallacies (Lowder et al., 2018 and Ray et al., 2017).
Many studies have focused on the relationship between sociodemographic factors
and substance abuse (Lamptey (2005); Ranjan et al., 2010 and Simoni-Wastila &
Strickler (2011)). Little is known about their association with successful treatment
completion. Also, there is limited literature about the association between health
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insurance coverage and successful treatment completion. This cross-sectional and
secondary data analysis will expand knowledge by assessing the association between
sociodemographic factors, health insurance coverage, and treatment completion outcomes
for individuals abusing opioids.
Sociodemographic Characteristics and Opioid Abuse
The threat of substance abuse is a socially unacceptable truth, but it is also a
disorder and has emerged as one of the top public health challenges of the new century.
Globally, there is a growing trend in the number of individuals using substance abuse.
This global issue of substance abuse has been influenced by social, economic, political,
and psychosocial factors. The issue of drug abuse has contributed to rising tensions
among societies (Rather et al., 2013). To understand this social phenomenon, Rather et al.
(2013) investigates sociodemographic, and patients profile attending the drug
rehabilitation unit.
In the study by Rather et al. (2013), the authors conducted a descriptive study
using the Drug De-addiction Centre (DDC) at the local Police Hospital of Srinagar. A
total of 198 patients were interviewed (Rather et al., 2013). The study results found that
for those who abuse the drug, the mean age was 26.8 years, and 56% of respondents
belong to lower-middle class. Poly-substance abuse was noted in 91.9%, and that
medicinal opioids and cannabis were the most widely used substances abuse. Also,
76.8% of individuals started the initiation between 11 to 20 years old. Findings revealed
peer pressure and experiencing psychological distress were key drivers for drug use. The
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study also noted the prevalence of a co-morbid psychiatric disorder to be high (Rather et
al., 2013).
The study by Ranjan et al. (2010) also reported that substances abuse is a global
problem, but it recognized that societies used it for relieving pain and for pleasurable
sensations. Using a cross-sectional design, Ranjan et al. (2010) examined
sociodemographic factors that contribute to drug abuse among respondents aged 15 and
above. Researchers applied a two-stage sampling method to collect data in Malvani
location (India), and four areas were selected including MHB Colony (2728 houses),
NCC Colony (12420 houses), Akashwani Area (5443 houses), and Ambujwadi (3000
houses). Findings suggested that nearly 50 % tested positive for any single or multiple
drug abuse habit. Participants aged 15-34 accounted for 59.8% of drug abusers. These
outcomes were consistent with the previous study conducted by Gomes et al. (2018). For
illiterate or primary or middle school levels, 72.1% of drug abusers were reported. The
results also showed that 24.7% of drug abusers were illiterate compared to 16.9 % in
nonabusers’ group. 53.1% represented the semiskilled workers, and 27.2% accounted for
the unemployed group. 65.2% of men have initiated drug between the age of 15 and 24
years old, and 81% of them cited peer pressure as the main factor. In their conclusion,
Ranjan et al. (2010) noted that early age, illiteracy, low working status, and poverty are
key drivers for drug abuse and that peer pressure plays a key role in the initiation stage
for any drug abuse, especially for males. In their discussion, Ranjan et al. (2010)
recommended training for parents and teachers by health professionals to curb this
problem. This article is relevant because it investigates sociodemographic factors
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contributing to drug abuse. The present study will go further to investigate the association
between health insurance coverage and treatment completion.
Lamptey (2005) also investigated fifteen sociodemographic characteristics of
abusers compared characteristics of non-substance abusers. Several studies demonstrated
that drug abuse is a persistent issue among adolescents. Most of the substance abuse
occurred between the mid-tens and mid-twenties (Gomes et al., 2018; Kolodny et al.,
2015; McHugh et al.,2014 and Wisniewski et al., 2008). Similar trends are shown in
Lamptey (2005). According to Lamptey (2005), the age range of 15-24 years reported the
greatest substance abuse, representing 83% of the population of the abusers. The study
used a privately specialized clinic in Ghana to compared eighty-seven abusers to the
same number of non-abusers. Findings revealed that substance abuse in adolescent males
was statistically significant with p<0.05. Substantial variations between males and
females regarding drug abuse were reported with p<0.05. The results found 1/3 of
abusers abandoned their education early at the secondary level with p<0.05. Furthermore,
results from Lamptey (2005) revealed that over half of abusers’ parents were divorced,
separated, or never married. One final note was that the perception of parents ’attitudes
and perception of siblings did not play a role in shaping responders’ way to abuse drug
(Lamptey, 2005). Intervention plans targeting the above sociodemographic factors could
ameliorate the rate of substance abuse and improve the overall health of the population.
The article mentioned affordability as a limitation to the study because only those who
can afford to visit the clinic are included. This study focused only on sociodemogarphic
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factors related to opioids abuse, but the current research will further investigate the
correlation between insurance coverage and successful treatment completion.
In the survey by Simoni-Wastila & Strickler (2011), the researchers sought to
approximate the frequency of prescription drugs problem and its associated risk factors.
The survey applied data from the National Household Survey on Drug Abuse. A total of
4,049 respondents were included in the survey. Variables such as race, age, gender,
marital status, urbanicity, education, work status, health insurance, income, and general
health status were considered in the survey. Results found that 1.3 million individuals
(15.5%) were considered as having an issue with a prescription drug. Having poor health,
drinking alcohol, unmarried, having age of 35 and above, white race, and being female
are predictors for prescription drug abuse. But full-time employment showed to have
protective effects against the prescription drug problem. The strength of this study is that
it was one of the first research emphasizing on the occurrence of issues related to
prescription drugs and the underlying risk factors that are related to their use. This
secondary data analysis will further explore the variables relationship with treatment
completion for opioids abuse.
Moreover, Swendsen et al. (2009) studied the prospective associations between
sociodemographic variables and drug addiction using data from the National Comorbidity
Survey (NCS) and the NCS Follow-up survey. Similar to previous studies, this survey
noted that the health effects of drug dependence (disorders) has been classified among the
global public health urgencies. Many studies have demonstrated strong correlations
between these disorders. Epidemiological studies have specifically found the prevalence
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of drug disorders to be linked to gender, younger age, lower education, unmarried status,
low income, and other variables reflecting disadvantaged social status. This is consistent
with the findings of many investigations (Lamptey (2005); Ranjan et al., 2010 and
Simoni-Wastila & Strickler., 2011). This survey used a total sample of 5,001 participants
from the National Comorbidity Survey (NCS) and the NCS Follow-up survey aged 15-24
years old, representing 87.6% baseline sample. Findings of the investigation revealed that
many sociodemographic variables like in earlier studies are strongly correlated to drug
addiction disorders like age, low education, ethnicity, and occupational. But, others like
sex, residence, and number of children were not related (Swendsen et al., 2009).
Swendsen et al. (2009) have practical recommendations targeting the most vulnerable
populations. The study is significant for its emphasis on drug disorders and
sociodemographic correlates. A strength of the study is its use of a large and nationally
representative sample. The limitation of this survey is its assessment at baseline. This
study will further explore the relationship between health insurance and treatment
completion for opioids abuse.
Farhat et al. (2015) discussed specifically opioid dependence. The aim of the
survey was to find out whether the sociodemographic profile is linked to the trend of
opioid-dependence in patients at a treatment center in India. The survey noted that
dependence to opioids contributed to high morbidity and mortality and can result in a
high prevalence of psychiatric illnesses. A cross-sectional design has been performed at
addiction rehabilitation Centre of Institute of Mental Health and Neurosciences. A total
of 200 opioid subjects were recruited at the treatment center, and all of them fulfilling the
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American Psychiatric Association's Diagnostic and Statistical Manual of Mental
Disorders (Farhat et al., 2015). The conclusions of the survey suggested that being young
was associated with opioid abuse. Prescription diversion was the main reason for drug
abuse, and peer pressure was highly correlated with initiating substance or drug abuse.
However, self-motivation was the key driver for seeking treatment (Farhat et al., 2015).
The study proposed a multidisciplinary collaboration or approach to tackle illegal and
non-authorized use of prescription opioid and bring the issue of drug abuse under control.
The limitation of the study was that it used a smaller sample, which has the potential of
affecting the validity and reliability of the overall outcomes.
Many cross-sectional studies have investigated sociodemographic factors with
opioid abuse. A survey by Tavares et al. (2004) sampling 27,990 students aged 10-19
years old, found a linear correlation between social class, age, and opioid abuse. Results
also found being divorced, unemployed, and place of residence to be strongly correlated
with drug abuse. In similar trend, Henkel (2011) found that unemployment was not only
associated with drug abuse it can also augment the risk of relapse after drug addiction
treatment. But the study found the religious belief to be protective against drug use.
Another survey by Gul & Sharma (2017) examined sociodemographic factors and trends
of drug abuse among subjects at a rehabilitation center using a sample of 300 participants
averaging 29.8 years old. The results of the study found opioids abuse to be prevalent in
179 (59.67%). Findings demonstrated that sociodemographic variables such as marital
status (unmarried), low educational level, place of residence (rural), and low occupational
level to be significantly correlated with drug abuse (Gul & Sharma, 2017). These findings
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are consistent with previous studies. The current investigation will learn more about the
association between health insurance coverage and successful treatment completion.
Research Involving Drug Treatment
The opioid epidemic has become a public health crisis that affects people of all
ages. Opioids are generally designed to relieve pain and can be very addictive. Licit
substances (e.g., oxycodone, hydromorphone) and other illicit drugs like heroin are
classified as opioids (Sanger et al., 2020). The use of opioid prescriptions can lead to
opioids use disorder. Evidence suggested that in 2017, more than 2.1 million individuals
suffered from an opioid use disorder because of prescription opioids abuse (Sanger et al.,
2020). Opioid misuse has been increasing since 2000, and an estimated 586,000 people
have been affected by a substance use disorder in the United States (Maglione et al.,
2018). It has been reported that a high proportion of the population suffering from
substance use disorder failed to enroll and receive adequate treatment services (Curtis,
2013). Also, the refusal for substance abusers to undergo treatment can potentially,
among others, increase the prevalence in mortality, lead to loss of income, alter an
individual’s physical functioning, and bring up societal harm (Curtis, 2013). The need to
treat substance disorder remains imperative, and a successful treatment completion can
have positive outcomes and reduce treatment readmissions (Marie et al., 2015).
Further, Turan &Yargic (2012) identified various factors that influence treatment
completion, including individuals’ demographics, substance type and route of
administration, the environment, and service settings or treatment program. But the
authors recognized that successful substance treatment completion depends on
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individuals’ acceptance to seek treatment and their level of engagement to stay the course
(Turan &Yargic, 2012). Furthermore, it had been revealed that the completion of
treatment for substance use disorder produces meaningful outcomes than hasty retreat or
withdrawal from treatment programs (Curtis, 2013). While there is a pressing need to
address prescription opioid abuse and its underlying health consequences, the correlation
between health insurance coverage and treatment completion outcome has often been
explored. This study will examine the health insurance coverage for opioid users in
Indiana and their correlated successful treatment completion.
In a secondary data analysis, Marie et al. (2020) used the Treatment Episode
Datasets-Discharge (TEDS-D) from the Substance Abuse and Mental Health Services
Administration to examine the association between opioid admissions treatment referral
source and successful treatment completions. The Treatment Episode Datasets-Discharge
collects substance abuse data from funded public and private facilities in the United
States and comprises about 1.5 million admissions annually (Marie et al., 2020). This
study analyzed TEDS-D datasets from 2006-2010 using a large sample of N = 2,909,884
population. This study used a chi-square test and Logistic regression for data analysis.
Statistical analysis of the sample showed that healthcare professionals' referrals with
lower successful treatment completion rates compared to other referral sources [OR =
0.72, 95% CI 0.70 – 0.75; p < 0.0001]. Also, the results demonstrated that admissions for
prescription opioids significantly lower treatment completion rates than other substances
(Marie et al., 2020). These findings were significant because they might provide insight
to target healthcare professionals to improve screening and referral to address the
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ongoing opioid crisis. Although the study assessed the correlation between treatment
completion and referrals, it did not assess clients' health insurance coverage to see
whether it plays a role in the treatment outcomes. This study intends to fill this gap.
In another research, Turan & Yargic (2012) assessed the association between
sociodemographic factors, substance use, and criminal activities on successful treatment
completion. A total sample of 115 subjects aged 18 and older participated in the survey.
Participants in this study were individuals for substance abuse treatment follow-up who
were on probation at the Istanbul Probation and Help Center in Turkey. The study aimed
to examine treatment completion rates on substance abuse among individuals on
probation, substance use characteristics, and criminal activities (Turan & Yargic, 2012).
This study's primary dependent variable was treatment completion, and the independent
variables (predictors) consisted of sociodemographic factors, substance use types, and
criminal history. Chi-square test, Fisher's exact test, and logistic regression were
performed to analyze data. The study found the treatment completion rate to be at 59.1%,
while non-completers represented 40.9%. The overall results demonstrated that
sociodemographic factors were not statistically significant contrary to previous studies.
However, the findings revealed statistical significance between substance use types and
criminal activities on treatment completion (Turan & Tragic, 2012). The study might
have practical ramifications in designing intervention strategies to tackle the problem of
substance abuse and improve treatment outcomes. Nonetheless, the inclusion of small
sample size, fewer females (only five of them took part in the study), and the selection of
individuals aged 18 and older constituted some of the limitations of the research and
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might affect the validity of the study. However, the study recommended further
investigation be conducted that includes a larger sample with more females and
adolescents for more meaningful outcomes. Overall, this study is significant because it
explored the association between sociodemographic factors, substance use types, and
treatment completion on substance abusers. The current secondary data analysis will
explore further the impact of health insurance coverage on treatment completers.
Moreover, the study by Sanger et al. (2020) investigated the correlation between
the source of first opioid exposure and treatment outcomes. The authors used a systematic
review and meta-analysis to carry out their investigation. The database searches used
included EMBASE, MEDLINE, PsycINFO, and CINAHL (Sanger et al., 2020). During
the analysis, 27,345 articles had been examined; the investigators utilized five
observational studies in their mixed-method analysis (qualitative and quantitative). The
findings of this investigation revealed that individuals who were initially exposed to
opioids via prescription had less likelihood of using illegal opioids while undergoing
medication-assisted treatment than those exposed to recreational drugs. This systematic
review analysis found that initial exposure to opioids via prescription or recreational
means can impact treatment outcomes for opioid addiction (Sanger et al., 2020). Findings
revealed that no significant relationship was found in treatment length between
prescription opioid and recreational use initiation. The study suggested that increase
prescription of opioids can contribute to a high prevalence of opioid use disorder.
However, the implementation of a new approach can improve OUD's treatment outcomes
(Sanger et al., 2020). The study's strength was its methodological nature, enabling the
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investigators to employ screening approaches that involve all studies. However, one of
the study's limitations was the lack of adjusting for confounding variables, which might
affect the validity of the outcomes. Another limitation was that only data from North
America and Australia were analyzed, which might affect the generalization of the
outcomes. This study seemed significant because it raised the public health concern of
opioid prescription and its contribution to opioid use disorder while focusing on their
influence related to treatment outcomes. The current secondary data analysis will look
further to assess sociodemographic factors and the impact of health insurance on
treatment completion rates.
Treatment for opioid addiction is important to improve the well-being of those
affected. It has been well-documented that access to medications for opioid use disorder
in residential addiction treatment facilities can be effective in individuals with such a
problem (Huhn et al., 2020). Despite substance abuse treatment availability, many
challenges still exist, including accessibility and lack of insurance coverage, among many
others (Huhn et al., 2020). In a study conducted by Huhn et al. (2020), the investigators
assessed the accessibility and application of MOUDs in residential addiction treatment
facilities. The purpose of the study was to investigate whether there are differences
between access to MOUDs and their use in residential treatment facilities. It also assessed
the relationship between facility-level with access to MOUD and admissions-level. The
inquirers applied a cross-sectional study design by examining large data surveys from the
2017 National Survey of Substance Abuse Treatment Services, 2017 Treatment Episode
Data Set–Admissions and state-level opioid overdose mortality rates state-level Medicaid
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coverage (Huhn et al., 2020). Descriptive statistics and logistic regression were
performed in this analysis. Findings revealed that individuals who were admitted for
treatment were predominantly men (67 %%), White patients (74%), and those aged 25-54
(81%). The study results showed that only 1.3% of treatment facilities offered all
MOUDs to those affected, and 60% did not. Also, residential facilities offering XR-NTX
generated greater odds of offering both buprenorphine and methadone with [OR, 22.93;
95% CI, 17.95-29.28; P < .001] and [OR, 6.73; 95% CI, 3.33-13.62; P < .001],
respectively. Most importantly, the study results suggested that individuals with opioid
use disorder and seek treatment at residential facilities where the care was expected to be
of quality failed to receive the care they needed (Huhn et al., 2020). One limitation was
that facilities reporting for individuals receiving MOUDs might not be known, which
might affect the study's generalizability. Overall, the study and its conclusions seemed
significant. It called for the need to address the ongoing problem of the opioid epidemic
in the United States while restricting access to those who need it. There is an existing
belief that most patients do not access quality care because of a lack of health insurance
coverage. The current secondary data analysis proposes investigating further and whether
there is an association between health insurance and treatment completion for opioid
users.
A survey by Brown (2010) examined predictors of substance abuse treatment
completion in drug court. The survey's measured demographic profiles, socioeconomics,
substance use, and criminal justice background of participants. The number of subjects
included in the study was N=573. Bivariate and multivariate logistic regressions were
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performed to assess such associations (Brown, 2010). Bivariate logistic regression
revealed that being unemployed, belonging to the non-whites race, and having the highest
grade completed were among predictors of substance abuse treatment completion.
Multivariate regression was performed and demonstrated that unemployment, lower
educational attainment, and cocaine were correlated with failure to complete treatment.
Similar outcomes were found by Knight et al. (2001). However, the use of administrative
data and self-reporting were considered limitations of the study (Brown, 2010). However,
Newton-Howes & Stanley (2015) rebutted the findings and found that primary,
secondary, high school, and college levels compared to graduate-level were predictive of
a greater likelihood of treatment completion. This study seemed significant to the current
research because it assessed demographic factors that predict failure to substance abuse
treatment.
Besides, Suntai et al. (2020) examined racial differences related to substance use
treatment completion among older adults using a cross-sectional design. The study aimed
to ascertain the extent of racial discrepancies regarding substance use treatment
completion among older adults. The study analyzed the Treatment Episode Data from the
Substance Abuse and Mental Health Services Administration (Suntai et al., 2020). Chisquare tests, bivariate, and multivariate logistic regression were utilized to analyze the
data. Findings showed that Blacks were less likely to complete a substance use treatment
program than Whites with OR = 0.630. Also, males were more likely to complete
treatment than females with OR = 1.288. There no difference found in marital status. But
the survey found that individuals not in the labor force had lower completion rates than
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those employed with OR = 0.799. Similar trends were found in the survey conducted by
(Bazargan-Hejazi et al., 2016). This survey was meaningful because it assessed treatment
completion predictors in outpatient, residential facilities and utilized a cross-sectional and
secondary data analysis to report their findings.
Nonetheless, Guerrero et al. (2014) investigated gender discrepancies related to
substance abuse treatment service use and outcomes within racial and ethnic groups. The
survey used a prospective longitudinal design from the National Treatment Improvement
Evaluation Study (NTIES) longitudinal in the United States. Descriptive statistics, chisquare, and analysis of variance were performed in this study. The study's findings
revealed that women from all subgroups benefited from services and treatment outcomes
compared to men (Guerrero et al., 2014). Besides, the study found that gender as a
moderator in the analysis. However, it found that females were more likely to enter
residential treatment facilities. There was no statistical difference between gender and
treatment completion with (OR: 0.93, 95% CI: 0.86–1.00) [Bazargan-Hejazi et al., 2016].
Another survey also found no gender differences in substance abuse treatment (Brown,
2010). The current study will assess similar demographic characteristics and their
association with treatment completion outcomes.
A study by Stahler & Mennis (2020) also examined to see if medications for
opioids use disorder (MOUD) can lead to treatment completion and retention in shortterm and long-term residential programs. The study used large datasets from the 2015–
2017 TEDS-D (Treatment Episode Dataset-Discharge) for opioid using adults in
residential treatment. Descriptive statistics, chi-square, bivariate logistic regression, and
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multiple logistic regressions were applied to carry out the analysis. Findings of the study
showed that in short-term residential treatment, MOUD was associated with a greater
likelihood of treatment completion (OR = 1.404) and increased retention rate (OR =
1.337) [Stahler & Mennis, 2020]. However, in long-term residential treatment programs,
MOUD was less likely to complete treatment (OR = 0.743) and found no difference in
retention (Stahler & Mennis, 2020). The significance of this study was that it evaluated
predictors for short-term and long-term residential treatment completion and retention,
part of the purpose of the current. However, it failed to report the association between
participants' sociodemographic characteristics and short-term and long-term residential
treatment completion and retention outcomes.
Health Insurance Coverage and Substance Abuse Treatment
Opioid abuse has been affecting Americans from every age group. Studies
suggested that many individuals have died from opioid abuse or opioid-related substance.
In 2018, the CDC reported three quarters (70%) of total deaths in the United States
attributed to opioids (CDC, 2020). Data revealed that licit prescriptions of opioids and
street opioids play a significant role in this skyrocketing death rate. The good news is that
treatment exists in tackling substance abuse in general and, specifically, opioids abuse.
Huhn et al. (2020) recommended that the residential treatment facility setting seemed to
be the most effective treatment-level for dealing with this public health issue. However,
many barriers might impede the successful completion of treatment, including health
insurance coverage and access to services utilization. Implementing evidence-based
substance use treatment by increasing service utilization can reduce mortality and
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morbidity due to substance abuse (Feder et al., 2019). It had been shown that only 10% of
those affected by substance use disorder could access treatment (Feder et al., 2019). The
reason for that was the lack of health insurance coverage that refrained people from
seeking treatment for opioid use disorder. People with low socioeconomic status were
more vulnerable. The relationship of health insurance coverage with opioid abuse and
access to treatment services has often been explored, and this study intended to do so.
In the article by Feder et al. (2019), the researchers sought to understand the
impact of health insurance on individuals using injectable drugs. Using the AIDS Linked
to the Intravenous Experience (ALIVE) data, the investigators extracted a sample size of
1724 adult participants who reside across the Baltimore area in Maryland. Among
variables assessed by the researchers included dependent variables (Receipt of specialty
substance use treatment, Receipt of buprenorphine, and having a usual source of medical
care) and the independent or predictor variable of self-reported health insurance status
(Feder et al., 2019). Data were analyzed using descriptive statistics and logistic
regression models. The results showed the participants' mean age to be 51, and 30 percent
of them were HIV tested positive. Also, males have a higher frequency of visits (2/3),
while 90% of participants were African Americans. The most striking outcomes exhibited
a statistically significant correlation between insurance type use and treatment receive
with z = 2.7 and p < .01. Findings revealed that having health insurance coverage had
greater odds (3 times) of getting buprenorphine treatment than those who lacked
insurance.

62
Furthermore, it showed that having insurance was strongly correlated with higher
medical care use (Feder et al., 2019). Finally, it demonstrated that holding health
insurance can be associated with the use of specialty substance use treatment (OR 2.0,
95% CI 1.6 to 2.5). The findings were significant because it might enable to design
interventions that expand health insurance to those uninsured. However, the study had
some limitations. The study was able to assess only treatment to buprenorphine. But the
study had not assessed Methadone and Naltrexone treatments and their association with
having insurance. Also, the study could not control for all confounding factors, and the
sample size was predominantly African American, which might affect the
generalizability of the outcomes. The current secondary data analysis will assess whether
acquiring health insurance predicts treatment completion outcomes for opioid users.
Another article by Cummings et al. (2014) discussed private health insurance
coverage and specialty treatment admissions for substance abuse disorder. The survey
aimed to assess the association between private health insurance and the receipt of
treatment for specialty substance use disorder. The study compared the receipt of
specialty for substance abuse treatment between uninsured and individuals having private
insurance. Data from the National Survey of Drug Use and Health or NSDUH using a
cross-sectional design. A large sample of 177,462 people aged 18 to 64 participated in the
survey (Cummings et al., 2014). Among the variables of interest assessed were receipt of
specialty treatment for substance abuse (inpatients and outpatients) from rehabilitation
centers (dependent variable) and health insurance coverage on categorical level
(Cummings et al., 2014). Also, sociodemographic characteristics were evaluated,
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including gender, marital status, age, race/ethnicity, employment status, income level
(Cummings et al., 2014). Findings revealed that private insurance was significantly
correlated with the increased use of any specialty substance use disorder care for
individuals experiencing alcohol addiction with a p-value <0.05 (Cummings et al., 2014).
Logistic regressions were performed to establish an association between the dependent
and independent variables. Cummings et al. (2014) further reported that cost and lack of
health insurance coverage were among the main problems’ individuals face for substance
abuse treatment. In another survey regarding the lack of insurance coverage in workers,
the outcomes demonstrated that uninsured workers have a higher likelihood of using
alcohol and other illicit drugs than those who were insured. It further showed uninsured
workers lacked drug assistance programs known as EPAs by employers than insured
workers (Miller et la., 2007). However, Cummings et al. (2014) suggested that the recent
enactment of the Mental Health Parity and Addiction Equity Act (MHPAEA) in 2008 and
the Affordable Care Act (ACA) of 2010 were both designed to expand health insurance
coverage for substance use disorders to improve treatment outcomes. Although
Cummings et al. (2014) did not say whether an association existed between the selected
sociodemographic profiles, a survey by Allcock et al. (2019) found a marked correlation
between health insurance coverage and gender, education, and income. The current study
will expand further in assessing such association.
A study by Mojtabai et al. (2020) investigated private health insurance use with
substance disorder treatment. In contrast with Cummings et al. (2014) findings, the
survey by Mojtabai et al. (2020) examined sociodemographic factors and found that
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having coverage was statistically significantly associated with receiving treatment with
[OR = 2.09, 95% CI = 1.61–2.72, p < .001]. Also, the results from Mojtabai et al. (2020)
found that participants with coverage were older than those lacking coverage (60.8% vs.
43.7%). Those with having coverage tend to be more educated than those without
coverage (58.7% vs. 50.4% had any college education, p < .001) and gained significant
family income than those without coverage (77.7% vs. 61.6%) [Mojtabai et al., 2020].
Further, Allcock et al. (2019) assessed sociodemographic patterns associated with health
insurance in Namibia using a large sample of 14,443 aged 15 to 64 years. The survey
applied multivariable mixed-effects Poisson regression analyses. The results of the study
by Allcock et al. (2019) demonstrated that health insurance was associated with health
service utilization and was independently associated with sex, education, and wealth.
These findings were significant. The current study will further investigate the association
between sociodemographic factors and treatment completion for opioids abusers and the
association between health insurance and treatment completion.
Another study by Olfson et al. (2018) assessed variations in private insurance
coverage and behavioral treatment for individuals aged 19 to 35 years after implementing
the Affordable Care Act on provisions of insurance coverage. The researchers applied a
cross-sectional design and extracted from the 2008 to 2016 National Surveys on Drug
Use and Health (NSDUH). The survey measured Health insurance coverage type and
treatment for substance use disorders. Additionally, the survey assessed
sociodemographic variables, including income, marital status, student status, and
employment. Structured interviews were used in evaluating substance use disorders and
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mental health issues by applying the Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition (DSM-IV) [Olfson et al., 2018). Findings of the survey
revealed a significantly more significant increase in private insurance for individuals
aged 19 to 25 years compared to 26 to 35 years with (7.7 % points; P < .001) and (1.2 %
points; P = .02), respectively (Olfson et al., 2018). Also, the study results found among
patients with selected substance use disorders, there was a significantly greater coverage
increase for individuals aged 18 to 25 years than for 26 to 35 years (9.0% points; 95% CI
= 5.5%, 12.5%). It found that the younger age group with substance use disorders had
significant gains in coverage (Olfson et al., 2018).
Treatment Options for Opioid Abuse
Despite the devastating health consequences of opioids abuse, there are various
treatments available for opioid dependence or abuse (Stotts et al., 2009). However,
Cummings et al. (2014) suggested that many individuals with substance abuse or drug
problems cannot access care because of lack of health insurance and the high costs of
service provided. Stotts et al. (2009) identified two ways for treating opioids dependence,
including opioid maintenance treatment and detoxification, and in many cases, patients
utilize both. The most recommended medications for opioid addiction include agonists,
partial agonists, and antagonists (Stotts et al., 2009). Agonist and partial agonist
medications are administered for maintenance and detoxification. The antagonist is used
to enhance outcomes (Stotts et al., 2009). The most common agonist medication used for
opioid maintenance and detoxification is Methadone. Buprenorphine is a partial agonist
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for opioid dependence. Naltrexone is administered as an opioid dependence antagonist
(Stotts et al., 2009).
-Methadone: Methadone is used for replacement therapy for heroin and other
opiates dependence. A dose ranging from 80 – 150 mg is recommended with 20-30 mg
starting daily dose. The dose is increased by 5 or 10 mg gradually until the maximum
dose is attained (Stotts et al., 2009). Methadone maintenance treatment or MMT has
shown to be effective in improving treatment retention and outcomes and lowering
mortality rates (Stotts et al., 2009). However, there is growing evidence that Methadone
can increase relapse for opioid dependence (Stotts et al., 2009). The use of methadone is
known to be correlated with cardiac effects (Stotts et al., 2009).
-Buprenorphine: Is used as a partial agonist to control opioid withdrawal
symptoms. The recommended oral for Buprenorphine oral is 24 or 32 mg. Partial agonist
use has decreased the risk of overdose and improved treatment retention outcomes (Stotts
et al., 2009). But Stotts et al. (2009) suggested that partial agonist might have the ability
to reduce Buprenorphine optimal efficacy.
-Naltrexone: Naltrexone is administered orally and is known as a long-acting
opioid antagonist that has proven effective for preventing relapse of alcohol and opioid
dependence (Stotts et al., 2009). Fifty (50) mg of naltrexone is recommended. Higher
doses of naltrexone are sometimes administered for a longer duration of action (Stotts et
al., 2009). However, patients who use naltrexone can experience some side effects such
as headache, nausea, abdominal pain, dysphoria, and depression (Stotts et al., 2009).

67
These literatures were selected because they assessed key variables in this analysis
(independent and dependent variables).
Existing Policies for Opioid Abuse
Many public health initiatives have been implemented to tackle the growing
problems of higher prevalence of opioid prescription misuse nationwide and across local
jurisdictions. In 2006, CDC had undertaken robust efforts to track better and understand
data related to the opioid overdose epidemic. In that optic, CDC has crafted five (5)
strategies designed to prevent opioid abuse, overdose, and deaths. Monitoring cases of
abuse using surveillance and research, involving tribal leaders, local and State
jurisdictions, providers, and payers are among the initiatives. CDC also was committed to
empowering consumers to make choices and to partner with public safety (CDC, 2019).
Many studies have also proposed and implemented treatment and preventive measures
related to opioid abuse. Treatment measures such as the creation of de-addiction centers
have been used to help those who are suffering from opioid use disorder (Farhat et al.,
2015; Heydari et al., 2014 and Tetrault and Butner ., 2015). Other studies focused on
education-based interventions to help them abandon opioid prescription abuse (Morales
et al., 2019; Tetrault and Butner (2015); and Tze et al., 2012).
One of the important initiatives implemented in Indiana State to curb the opioid
crisis is the NextLevel Recovery Indiana. The initiative focuses on prevention, treatment,
enforcement, and training for healthcare professionals. The NextLevel Recovery Indiana
provides access to resources, emergency personnel, community leaders, and supports to
individuals with opioid use disorder and their families (Indiana State Department of
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Health, 2019). Indiana state applies the Indiana Scheduled Prescription Electronic
Collection and Tracking (INSPECT) surveillance system to track down and address
prescription drug abuse and diversion (ISDH, n.d).
Summary
The prevalence of prescription drug abuse increased significantly and faster in
recent years in the United States. Opioids remained the most widely abused prescription
drugs and show to contribute to the worsening of the epidemic. Many studies and
literature reviews recognized opioid abuse as the most pressing challenge in the public
health field. They also demonstrated the need to address such a growing public health
problem. Several studies showed that opioid abuse led to high mortality and morbidity
rate (Gomes et al., 2018; Meyers et al., 2014; and Morales et al., 2019).
Various studies investigated sociodemographic factors with opioid abuse.
Findings from these studies demonstrated a marked association between
sociodemographic profiles and prescription opioid abuse. The outcomes noted that
sociodemographic factors like race, sex, single, younger age, residence, and
unemployment are strongly correlated with prescription drug abuse (Lamptey (2005);
Ranjan et al., 2010 and Simoni-Wastila & Strickler (2011)). But other studies found few
sociodemographic factors were not related to opioid abuse. Nevertheless, the association
between sociodemographic factors for opioid abuse and their relationship with treatment
completion had been assessed. It had been shown that sociodemographic factors are
significantly correlated to opioid abuse treatment completion. But other studies disputed
such findings. Additional studies evaluated the association between insurance coverage
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types and specialty treatment for substance use disorder, more specifically with alcohol,
and found that individuals with coverage have better access to treatment. Others disputed
such a claim. The implementation of recent regulations in 2008 and 2010, such as
MHPAEA of the ACA, respectively by congress, has led to the expansion of coverage for
substance use disorder. The current quantitative cross-sectional research will further
assess the association between sociodemographic attributes, health insurance coverage,
and treatment completion for opioids abuse in Indiana. Despite high expenditure for
substance use and opioid abuse, but the crisis continues to grow. This literature review
offered the necessary tool for the research method (chapter 3), which incorporates the
research questions and the design format to carry out this study. The research method
section will discuss the recruitment of subjects, sampling method used, collection of data,
ethical procedures, and threats to validity.
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Chapter 3: Research Method
Introduction
This cross-sectional and quantitative research design sought to investigate the
association between sociodemographic factors and treatment completion for opioid
abusers in Indiana. The study also sought to examine the association between health
insurance coverage and treatment completion for opioid abusers in Indiana. The
completion of this study will provide another perspective for improving the treatment and
retention for opioid abusers in Indiana, including for individuals having a problem
accessing care because of a lack of health coverage. Further, the outcomes of this study
would help expand insurance coverage and improve access to care. This cross-sectional
and quantitative research was guided by the questions below:
1. Is there any association between sociodemographic factors and treatment
completion for opioid abusers among residents in Indiana?
2. Is there any association between health insurance coverage and treatment
completion for opioid abusers in Indiana?
3. Is there any association between health insurance coverage and treatment
completion for opioid abusers in Indiana after controlling for sociodemographic factors?
This chapter will discuss the study’s research design and its rationale and the
detailed research methodology, including the population study, sample size, sampling
procedures, and data collection. Besides, the chapter will describe the instrumentation
and operationalization, the data analysis plan, and threats to validity of the study. Finally,
an overview of the ethical research procedures and a summary were presented.
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Research Design and Rationale
I will use the 2017 Treatment Episode Data Set Discharges (TEDS-D) from the
Substance Abuse and Mental Health Services Administration (SAMHSA), a branch of
the U.S. Department of Health and Human Services. A quantitative cross-sectional study
design was applied. The data used were deidentified and were publicly accessible.
Indiana data were extracted from the datasets for this analysis. This study sought to
evaluate the association between sociodemographic factors, substance abuse (opioid only
reported at admission), and treatment completion for opioid abusers. Besides, the extent
of the relationship with treatment completion will be assessed when controlling for the
selected sociodemographic factors. There is limited literature on health insurance
coverage on treatment completion. This study will fill the gap by examining the
association between health insurance coverage for treatment and successful treatment
completion for opioid abusers at discharge.
Dependent and Independent Variables
The primary dependent variable (DV) considered in this study was successful
treatment completion status at discharge. Treatment completion in this dataset was
defined as “all parts of treatment plan or program were completed” (TEDS-D, 2017).
This secondary data analysis will apply this definition concept. The outcome variable of
treatment completion was measured on a categorical level. Therefore, the researcher used
the variable successful treatment completion as “Treatment completed” or “Treatment not
completed” for any reasons such as “dropped out of treatment, terminated by the facility,
transferred to another treatment program or facility, incarcerated, death, and other.”
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Another outcome variable involved in this research was opioid abuse (opiates/synthetics
abuse) for individuals using opioids as their primary substance use.
The independent variables (IV) in this study included sociodemographic attributes
(education, gender, age, race, marital status, and employment) and health insurance
coverage at admission. The independent variables predict or forecast the values of the
dependent variable in the model (Statistics Solutions, 2019). In a research study, the
independent variable is tested to determine its relationship regarding an observed
phenomenon (Siegle, n.d).The selected sociodemographic attributes were measured as
categorical. Opiates/synthetics represented the substance reported at admission.
Opiates/synthetics were considered in this study as any substance use containing opioid
and drug morphine-like effects that individuals reported at admissions as their primary
substance use (TEDS-D, 2017). It included buprenorphine, codeine, hydrocodone,
hydrocodone, hydromorphine, meperidine, morphine, opium, oxycodone, pentazocine,
tramadol) [TEDS-D, 2017]. In this study, opiates/synthetics were measured as a
categorical variable. Finally, health insurance coverage was measured as dichotomous
(insured versus uninsured).
The research method best suited was cross-sectional and quantitative research
design. The rationale for choosing a cross-sectional study approach allows evaluating
whether there is a correlation between exposures (IV) and outcomes (DV) variables at
one time (Setia, 2016). Another justification for this study was the availability and
accuracy of the dataset, and it was inexpensive and timesaving. A cross-sectional design
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is the most convenient for public health planning, monitoring, and evaluation (Setia,
2016).
This study examined the correlation between sociodemographic factors (education
status, gender, age, race, marital status, and employment status) and opioid abusers in
Indiana. Additionally, the current research analyzed the association between health
insurance coverage at admission and treatment completion status for opioid abusers in
Indiana. The analysis of data was performed using SPSS. The researcher will run
descriptive statistics to display data summary. Also, Chi-square and logistic regression
were performed. The outcomes would enable identifying specific sociodemographic
attributes and health insurance coverage that predict successful treatment completion
status for opioid abusers in Indiana. Understanding these factors could help promote
positive social change by implementing policies that expand health insurance coverage
and improve treatment outcomes for opioids abuse in Indiana. This may improve
morbidity and mortality rates related to opioid abuse and overdoses in Indiana.
Much research had been conducted to explore sociodemographic factors with
opioids abuse but limited research on the association between health insurance coverage
and successful treatment completion. This research was intended to fill that gap.
Understanding the relationship between health insurance coverage and successful
completion of opioid abuse treatment is essential in the public health field. There is a
common belief that substance abusers having a government type of insurance or not
having insurance were more likely to be rejected for substance abuse treatment.

74
When completed, this study could design policies to expand health insurance
coverage for individuals dealing with substance abuse problems at the state and local
levels. Investigating the association between the selected sociodemographic factors,
health insurance coverage, and treatment completion for opioid abusers may help
promote positive social change. The study could help expand insurance coverage for
substance abusers, including opioid abusers and underserved individuals. This study's
findings would improve treatment outcomes and reduce morbidity and mortality due to
opioid abuse among Indiana residents.
Methodology
Population
Background of Indiana population characteristics
The state of Indiana is in the Midwest region of the United States. It is one of the
largest and most populated states ranking 38th and 17th, respectively. Indianapolis is the
capital and the largest city in the state. There are 92 counties in Indiana, and Marion
County, where Indianapolis seats, is the largest and most populated counties in Indiana.
According to the United States Census Bureau (2019), the population of Indiana was
estimated at 6,732,219 residents as of 2019. The racial distribution of the population
includes Whites (84.8%), Blacks (9.9%), Latinos (7.3%), Asians (3%), and the rest
represent Native Americans (U.S. Census Bureau, 2019). The population is composed of
50.7% females and 49.3% males. The percentage of individuals earning high school
degrees or higher is 88.6% and those with a bachelor’s or higher represents 25.9% (U.S.
Census Bureau, 2019). The state median household income was $55,725. Employed
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individuals were estimated at 3,275,056 while unemployed represented 112,310, and the
state unemployment rate stands at 3.3% (U.S. Census Bureau, 2018). The mean age was
estimated at 37.9.
The 2019 U.S. Census Bureau reported the preschool population in Indiana aged 0
to 4 to be 418,340. This number represents 6.2 percent of the general population
estimates. The school-age (5 to 17 years old) was 1,149,634 people, accounting for 17.1
percent. Estimates showed the population of individuals having college-age (between 18
and 24 years old) to be 659,745. This figure represents 9.8 percent of the total population.
Additionally, younger adults aged 25-44 account for 1,719,646 people, representing 25.5
% of the general population (U.S. Census Bureau, 2018). Furthermore, the same data
revealed the population of older adults between 45 and 64 years old to be
1,699,111people, accounting for 25.2 percent of Marion County population. Finally, the
population of individuals aged 65 and more was estimated at 1,085,743 people (16.1%)
[U.S. Census Bureau, 2018]. The above age distribution of the population showed
individuals aged 25-44 to be the greatest (25.5%), followed by older adults or 45-64 (23.7
%), school-age (17.1%), older people (16.1%), College-age (9.8%), and preschool (6.2%)
[U.S. Census Bureau, 2018.] Knowing these demographic characteristics of Indiana is of
paramount importance for undertaking this cross-sectional design study.
Target Population
I used the 2017 TEDS-D dataset to conduct this analysis. The Treatment Episode
Data Set Discharges or TEDS-D represents annual discharges from substance abuse
treatment facilities (TEDS-D, 2017). The dataset used does not record all admissions or
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discharges but report admissions to accredited treatment facilities for substance abuse
that receive local and federal funding. TEDS-D recorded information for individuals aged
12 and older (TEDS-D, 2017).
The current cross-sectional, quantitative research approach was applied to address
the severe problem of opioid abuse and overdoses that Indiana faced. McLeod (2014)
defined a target population as the entire group of subjects or individuals to which
investigators are interested in generalizing the outcomes. The target population involves
specific characteristics and is the group from which the sample may be drawn (McLeod,
2014). Evidence suggested that opioid abuse in the U.S affected younger people aged 2445 more than any other age group (Gomes et al., 2018). The attributable opioid-related
mortality was highest among adults aged 25-34- and 35-44-years. A similar trend was
seen in Indiana, and data showed that individuals aged 18 to 25 years old were more
vulnerable than other groups (NIDA, 2018). It had been shown that individuals aged 18
and older are predominantly the most affected by opioid abuse in Indiana and this crosssectional study was going to focus on this age group. It was expected to see the target
population to reach many thousand in Indiana.
Sampling and Sampling Procedures
Sampling Strategy
The present cross-sectional study sought to evaluate the relationship between
some sociodemographic attributes and successful treatment completion for opioid abusers
in Indiana. Sociodemographic factors were adjusted to evaluation their relationship with
abusers’ treatment completion. It further assesses the correlation between health
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insurance coverage and treatment completion for opioid abusers in Indiana. A simple
random sampling strategy was applied in this cross-sectional study. This type of sampling
seemed the most appropriate because of its tendency to use a probabilistic approach
where subjects have an equal chance of being selected, and the drawn sample is more
representative of the target population (Elfil & Negida, 2017).
Inclusion of participants comprised of the selected sociodemographic
characteristics (age, gender, race, education, employment status, and marital status),
opioids abuse reported at admissions as primary substance (other opiates/synthetic
abuse), completion of treatment at discharge, health insurance status, and being 18 and
older. Exclusion criteria included participants less than 18 years and all missing cases
following the missing at random (MAR) procedure. I used any precautionary measures to
ensure accuracy of data being analyzed.
Sampling Procedures
The sample size for this cross-sectional design study was determined by using the
power calculator, G*Power 3.1.9.7. The use of G*Power in this research helps to
determine an a priori practical compromise sample size. G*Power is a stand-alone, very
useful power analysis program for conducting various statistical assessments that are
frequently used in the social, behavioral, and biomedical sciences (Faul et al., 2009). For
the determination of sample size, it is essential to apply statistical power, which can help
the researcher to avoid type I and type II errors (Faul et al., 2009).
In this analysis, the parameters for calculating sample size were set on Z-Tests
since a probabilistic approach was applied, and logistic regression analysis was selected
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as the statistical test to be conducted. In addition, the medium effect size was set to be a
choice because setting the “a priori” effect size level that is too high or too low has the
potential of increasing the risk for error (Sullivan, 2012). Setting the effect size is
indispensable because, as stated by Sullivan (2012), it is the main finding of a
quantitative study. Further, a p-value can tell the reader about the real effect, but the pvalue cannot estimate the effect (Sullivan, 2012). We set an acceptable coefficient of
determination (effect size), also known as R square to be 0, representing a measure of the
proportion of variance between the variables and can vary from 0 to 1. Using the
G*Power with a confidence interval of 5 % and considering a power of 0.95, the
generated sample size for achieving empirical validity with two or more predictors was
estimated to be 988 participants. However, to ensure greater power, I used the entire
sample contained in Indiana datasets.
Table 1
Protocol of Power Analysis
z tests - Logistic Regression
Options: Large sample z-Test, Demidenko (2007) with var corr
Analysis: A priori: Compute required sample size
Input:
Tail(s)
= One
Odds ratio
= 1.3
Pr(Y=1|X=1) H0
= 0.2
α err prob
= 0.05
Power (1-β err prob)
= 0.95
R² other X
= 0
X distribution
= Normal
X parm μ
= 0
X parm σ
= 1
Output: Critical z
= 1.6448536
Total sample size
= 988
Actual power
= 0.9501283
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Z Tests: Protocol of power analysis for the determination of sample size and interactions
Analysis: A priori: Compute required sample size
Figure 1
G* Power Analysis for the Required Sample

Data Collection
Participants can be accessed through the 2017 TEDS-D archival data managed by
the Substance Abuse Mental Health Services Administration (SAMHSA). TEDS-D data
gathered information on individuals’ demographics, their substance abuse pattern, and
their admissions and treatment outcomes at discharges from all facilities receiving public
funds. The data collected in the 2017-TEDS-D concerned individuals aged 12 and older,
and the information reported from 46 states and the District of Columbia. The TEDS is
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composed of two major components, including admissions and discharges (SAMHSA,
2019).
Indiana data was extracted from the TEDS-D datasets, and participants in this
study were individuals who reported abusing opioids as their primary substance use. The
information gathered to be examined would include participants’ sociodemographics
(age, gender, race, educational level, employment status, and marital status), health
insurance coverage status, reported opioid abuse at admissions and completed treatment
at discharge. However, we estimated the sample size to be 988 participants using
G*Power tools. The population of individuals undergoing substance abuse treatment in
Indiana was estimated to be 21,000 people (SAMHSA, 2019).The collected data in the
TEDS-D were publicly available and de-identified. The material contained in the TEDSD document is presented in the public domain and does not require permission to be
accessible (SAMHSA, 2019). Data were accessible on Substance Abuse and Mental
Health Data Archive (SAMHDA) through CDC WONDER. Because TEDS-D was the
most trusted data sources for substance abuse and mental health, it is generally accepted
as reliable.
Instrumentation and Operationalization
Instrumentation
The survey instrument tool applied in this cross-sectional study to collect
information from participants was the Treatment Episode Data Set – Discharges (TEDSD) of 2017. Reported data concerned all U.S. facilities receiving public funds for
substance abuse treatment. Data collected come from admissions and discharges.
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Admissions components involved individuals’ demographic characteristics, primary,
secondary substance use, secondary substance use, tertiary substance use, route of
administration, frequency of use, age at first use, and source of referral to treatment
(SAMHSA, 2019). Besides, it included a number of prior treatment episodes and service
types. While discharges information included the type of service at discharge, length of
stay, and reason for discharge (SAMHSA, 2019). Only three states were excluded in
TEDS-D 2017, including Georgia, Oregon, and West Virginia, for lack of sufficient data
reporting (SAMHSA, 2019).
Operationalization
The researcher used the 2017 TEDS-D codebook in the definition of the variables
of interest.
Age: Using TEDS-D of 2017, the variable was used as the date of birth of the
patient at admission (SAMHSA, 2019). The variable was measured as categorical and
recorded into a different variable named Age_Group with four categories. The new
recoded age variable comprises of five subcategories, including 1= “18-34”, 2= “35-44”,
3= “45-54”, and 4= “55 and older”. Individuals aged less than 18 were excluded.
Education: The education variable was described in the TEDS-D as the highest
level of school years completed by subjects (SAMHSA, 2019). The variable has six
subcategories but was recoded into four subcategories, including [1=Primary (<8 years),
2=Secondary (9-11years), 3=High School (12years), 4=College (13-15years),
5=Graduate (16 and more)] for easier analysis. The researcher used education as a
categorical variable.
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Employment status: This variable specifies the subject’s employment status at the
time of admission and has four subcategories (SAMHSA, 2019). It includes “Full-time,
Part-time, Unemployed, Not in the labor force” (SAMHSA, 2019). The variable was
measured as categorical in this study.
Race: Is “a multidimensional social construct and is considered as a predictor of
exposure to external health risks posed by environmental, social, and behavioral factors”
(Ford & Kelly, 2005). In the United States, race is defined as “White, Blacks or African
American, Asian, American Indians and Alaska Native, Native Hawaiian and Other
Pacific Islander, or other (U.S. Census Bureau, 2019). The researcher applied the defined
variable in the 2017-TEDS-D. Race was recoded and considered in analysis as 1= Native
Americans (Alaskans, American Indians, Pacific Islanders), 2=Blacks, 3=Whites, and
4=All others (other single and two or more races). The variable was measured as
categorical. Latinos group was not listed in the TEDS-D survey.
Gender: Is defined as a social construct, representing biological and physiological
differences between both sexes (female and male) (WHO, 2020). The variable of gender
designates the subject’s biological sex (Male and female), as described in the 2017-TEDS
(SAMHSA, 2019). It was measured on the categorical level (1=Male and 2=Female).
Marital status: Refers to subject conjugal condition. This variable is termed in the
TEDS-D ‘‘Never married,’’ ‘Now married,” “Separated,” and “Divorced, widowed’’
(SAMHSA, 2019). The same definition of “marital status” was applied in this study as
categorical.
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Health insurance coverage: Designates the subject of health insurance status at
the time of admission (SAMHSA, 2019). The variable was measured as categorical and
encompassed various labels, including “Private insurance, Blue Cross Shield, HMO,”
“Medicaid,” “Medicare, other,” “None.” In this analysis, the variable was recoded into
HLTHINS_Group by combining “Private insurance” and “Government insurance” into
one category (1=Insured), and “None” (not having insurance coverage) was recoded into
another category 0=Uninsured.
Reason for discharges or discontinuance of treatment: “Indicates the outcome of
treatment or the reason for transfer or discontinuance of treatment” (SAMHSA, 2019).
The variable was used as categorical and had several subcategories, including “Treatment
completed,” “Dropped out of treatment,” “Terminated by the facility,” “Transferred to
another treatment program or facility,” “Incarcerated,” “Death,” and “Other” (SAMHSA,
2019). In this analysis, the variable was recoded into Reason_Group to form two
categories (1=Treatment completed and 0=Treatment not completed).
Opioid abuse: signifies other opiates/synthetics reported at admission by subjects
as their primary substance use, including buprenorphine, codeine, hydrocodone,
hydromorphone, meperidine, morphine, opium, oxycodone, pentazocine, propoxyphene,
tramadol, and any drug having morphine-like effects (SAMHSA, 2019). This variable
was measured as categorical. The variable stayed intact, as described in the codebook. It
has two subcategories, including 1= “substance reported” at admissions) and 0=
“substance not reported” at admissions for easier analysis.
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Data Analysis Plan
The data collected analysis involved the use of the Statistical Package for the
Social Sciences, version 25(SPSS). Indiana sub-data was extracted from the TEDS-D. All
missing data were eliminated following the missing at random (MAR) procedures to
ensure accuracy of the data. The independent or predictors variables considered in this
analysis were sociodemographic factors (age, gender, race, education, employment status,
and marital status) and health insurance status. The two independent variables were
measured as categorical. Whereas the dependent or outcome variables were identified as
binary. Opioid abuse (opiates/synthetics abuse) was defined as “Substance abuse not
reported” vs. “Substance abuse reported." The outcome variable treatment completion
was defined as “Treatment not completed” vs. “Treatment completed." This study's
research questions were answered, and hypotheses tested using statistical analyses such
as descriptive statistics, chi-square, and logistic regression.
Research Question 1: Is there any association between sociodemographic factors
and treatment completion for opioid abusers among residents in Indiana?
H01: There is no association between sociodemographic factors and treatment
completion for opioid abusers among residents in Indiana.
Ha1: There is an association between sociodemographic factors and treatment
completion for opioid abusers among residents in Indiana.
RQ2: Is there any association between health insurance coverage and treatment
completion for opioid abusers in Indiana?
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H02: There is no association between health insurance coverage and
treatment completion for opioid abusers in Indiana
Ha2: There is an association between health insurance coverage and
treatment completion for opioid abusers in Indiana
RQ3: Is there any association between health insurance coverage and treatment
completion for opioid abusers in Indiana after controlling for sociodemographic factors?
H03: There is no association between health insurance coverage and
treatment completion for opioid abusers in Indiana after controlling for demographic
factors.
Ha3: There is an association between health insurance coverage and
treatment completion for opioid abusers in Indiana after controlling for sociodemographic
factors.
It is essential to point out that descriptive statistics do not lead to conclusions
regarding any hypotheses that might have been formulated (Laerd Statistics, 2018).
Ultimately, descriptive statistics are just a way to describe the data analyzed. This makes
descriptive statistics more critical when analyzing data because of their ability to allow a
simpler interpretation of the data (Laerd Statistics, 2018). This can be done by presenting
the results in tables or graphs. The statistical test Chi-square is generally known for
testing correlations between categorical variables. In this analysis, the chi-square test's
null hypothesis considers that no relationship exists on the population's independent
categorical variables (Statistics Solutions, 2019). The Chi-square statistic is displayed as
an option when requesting a crosstabulation in SPSS. Logistic regression analysis is the
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appropriate choice to analyze when the dependent variable is dichotomous (Statistics
Solutions, 2020). Logistic regression is applied in describing data and clarifying the
association between one dependent binary variable and one or more variables (Statistics
Solutions, 2020). The expected results in this analysis will be presented in the form of
odds ratio (OR), confidence interval (CI), and p-value.
For Research Question 1 (RQ1):
Descriptive statistics were conducted to display data summary for
sociodemographic characteristics (age, race, gender, education, employment status, and
marital status). Preliminary chi-square tests and multivariate logistic regression between
sociodemographic attributes and opioid abuse (opiates/synthetics abuse) were performed
to evaluate their association. Besides, basic chi-square tests and multivariate logistic
regression were conducted to assess the relationship between sociodemographic factors
and treatment completion outcomes.
For Research Question 2 (RQ2):
Descriptive statistics were carried out to display health insurance coverage and
the outcome variable of treatment completion. The researcher used chi-square tests and
bivariate logistic regression to evaluate the relationship between health insurance
coverage and treatment completion.
For Research Question 3 (RQ3)
A multivariate logistic regression was run to assess the association between health
insurance and treatment completion after adjusting for sociodemographic factors (age,
race, gender, education, marital status, and employment status).
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Threats to Validity
It has been demonstrated that the main threats to the reliability and validity of
secondary data analysis evolve from the accuracy of the approaches used during the
primary collection of such data (Boo & Froelicher, 2013). Issues may come from survey
sampling, data collection, non-response, and missing data. The investigator did not
participate in the initial research design and data collection; it is imperative to
comprehend the accuracy of the dataset being investigated (Boo & Froelicher, 2013).
In this study, there might be potential threats to reliability and validity. SAMHSA
reported that an external factor, such as funding availability, could threaten the validity of
this study (SAMHSA, 2019). Evidence suggested that states with higher funding tend to
admit many substance-using individuals for treatment (SAMHSA, 2019).
On the other hand, funding constraints may lead states to limit their ability to
admit a larger number of substance abusers; hence, it enabled them to target only special
populations in their areas (SAMHSA, 2019). Another threat that might influence the
results was that several states considered many admissions for the same patient, meaning
data represent admissions only instead of the client (SAMHSA, 2019). Thus, data might
contain several entries for one client. This might potentially affect the reliability and
validity of the study. Also, non-response and missing information in the national survey
might influence the validity of the overall results.
However, the extracted data from Indiana, which was examined in this study,
seemed accurate. The data contained a large sample and an insignificant number of
missing cases. TEDS is also one of the nation's most dependable data sources for
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substance abuse and mental health. Researchers are urged to access and utilize SAMHSA
data repository files for public health purposes (SAMHSA, 2019). Therefore, TEDS data
files are accurate and trustworthy. In analyzing the data, the researcher used statistical
regression and randomization to overcome potential validity threats. Nonetheless, all
missing data from the extracted Indiana sub-dataset were eliminated using the MAR
process. Therefore, the statistical data analysis yielded accurate and precise results from
the study.
Ethical Procedures
Researching human subjects can lead to ethical challenges. Public health ethics
deal with recognizing, analyzing, and resolving ethical issues derived from public health
practice and research (Coughlin, 2006). Ethical challenges in public health are usually
linked to the necessity of public health professionals to obtain and use scientific
knowledge to protect the public's general health while respecting the rights of individuals
(Coughlin, 2006). Emphasizing ethical issues when conducting human subjects’ research
can facilitate effective planning, implementation, and improvement of public health plans
and research (Coughlin, 2006).
The present secondary data analysis study examined data from 2017 Treatment
Episode Data Set Discharges. The datasets were retrieved from Substance Abuse and
Mental Health Data Archive (SAMHDA), and Indiana subdatasets will be extracted. The
datasets were publicly available and can be accessed
at: https://www.datafiles.samhsa.gov/ dy-dataset/teds-d-2017-ds0001-teds-d-2017ds0001-nid18480. Data are de-identified and publicly accessible. When the data were
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initially collected, the researcher understood that a consent form was given to
participants, and the results will be used for future research. Therefore, participants’
confidentiality in this data analysis would not be affected.
Prior to analyzing the datasets in this study, the proposal was submitted to the
Walden Institutional Review Boards for review. Approval would be granted to the
investigator or researcher before the start of data analysis to ensure research compliance
with the university's ethical standards as well as U.S. federal regulations. Information
about opioid abuse subjects, including their demographics, substance use, health
insurance, and treatment completion status, were accessible from the public domain
through SAMHDA. In this secondary data, the information being treated would be
protected under pass-worded computer. There was no conflict of interest involved in the
process of this research, the dataset was publicly available.
Summary
Substance abuse is a growing socio-medical problem. The researcher applied a
quantitative cross-sectional design by extracting Indiana from the 2017 TEDS-D datasets.
The study analyzed the association between sociodemographic factors (age, gender, race,
employment, education, marital status) and treatment completion status for opioid abuse
in Indiana. Further, it assessed the association between health insurance coverage and
treatment completion. A simple random sampling strategy to draw a representative
sample was applied because of its ability to offer subjects an equal chance of being
selected. Included in this data analysis were individuals aged 18 and older. G*Power
software was used to determine the sample size of 988 participants from the target
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population of Indiana. The investigator performed various statistical tests, including
descriptive statistics, chi-square, and multivariate logistic regression, using IBM SPSS
version 25. This cross-sectional study's overall results will help promote positive social
change in Indiana by designing and implementing policies to reduce the opioid abuse
burdens. The next chapter (chapter 4) will discuss the introduction, data collection, and
study outcomes.
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Chapter 4: Results
Introduction
In this study, I examined the association between sociodemographic factors (i.e.,
age, gender, race, marital status, employment status, and education level) and successful
treatment completion outcomes among opioid abusers in Indiana aged 18 years and older.
The present study also sought to investigate the association between health insurance
coverage and treatment completion outcomes for opioids abusers in Indiana among
individuals aged 18 years and older. I formulated the following research questions along
with subsequent hypotheses to conduct this study:
RQ1: Is there any association between sociodemographic factors and treatment
completion for opioid abusers among residents in Indiana?
H01: There is no association between sociodemographic factors and treatment
completion for opioid abusers among residents in Indiana.
Ha1: There is an association between sociodemographic factors and treatment
completion for opioid abusers among residents in Indiana.
RQ2: Is there any association between health insurance coverage and treatment
completion for opioid abusers in Indiana?
H02: There is no association between health insurance coverage and
treatment completion for opioid abusers in Indiana.
Ha2: There is an association between health insurance coverage and
treatment completion for opioid abusers in Indiana.
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RQ3: Is there any association between health insurance coverage and treatment
completion for opioid abusers in Indiana after controlling for sociodemographic factors?
H03: There is no association between health insurance coverage and
treatment completion for opioid abusers in Indiana after controlling for sociodemographic
factors.
Ha3: There is no association between health insurance coverage and
treatment completion for opioid abusers in Indiana after controlling for sociodemographic
factors.
In this analysis, the investigator adjusted sociodemographic factors to evaluate the
association between health insurance coverage and treatment completion outcomes after
adjusting the potential confounding effects of age, gender, race, employment, education,
and marital status using multivariate logistic regression. Overall, chapter 4 will discuss
data collection process used and the results of the data analysis of the study.
Data Collection
This research used TEDS-D archival data from SAMHSA, a national collection of
annual discharges from substance use treatment services in 2017. TEDS-D represents
admissions to licensed or certified facilities by state agencies for substance use treatment
services; those facilities are mainly sponsored by states or drug agencies (SAMHSA,
2019). The TEDS-D is a nationally representative sample, although it does not include
all substance use treatment facilities in the United States. The data were de-identified and
were publicly available. Prior to analyzing the data, the researcher obtained the proposal's
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approval from Walden University Internal Review Board (IRB). The researcher IRB
approval on November 17th, 2020, and the approval number was 11-17-20-0721940.
Within two days after the IRB approval, I accessed the SAMHSA website, and
TEDS datasets were transferred on SPSS and stored in a password-protected USB key for
analysis. The researcher then extracted Indiana state (#18 in the codebook) data from the
national survey and analyzed the variables of interest. It included sociodemographic
attributes (i.e., age, gender, race, employment status, education level, and marital status);
health insurance coverage status; reported opioid abuse at admissions and completed
treatment at discharge. We expected the baseline for education, marital status,
employment status, gender, race, age, and health insurance coverage to be high school
level, single, full-timers, female, whites, age group 18-34 years, and insured,
respectively.
There was a total of 21,611cases generated for Indiana from the TEDS-D datasets,
which represented 1.3% of the total cases in the national survey. After the Indiana
datasets were analyzed and missing cases were removed, the number dropped to 20,822
cases. Following the inclusion and exclusion criteria, the analytic sample used in this
study was set to be 20,822. Using SPSS, descriptive statistics, preliminary chi-square
were applied. Additionally, bivariate and multivariate logistic regression analyses were
the main statistical tests used and the results were reported in odds ratio. The dependent
variables were treatment completion and opioid abusers. The independent variables were
health insurance and sociodemographic factors of education, marital status, employment
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status, gender, race, and age. The outcomes and independent variables were defined and
measured as follow:
Table 2
Variables and Coding
Variable
Age (IV)

Coding
1= “55 and older”
2= “45-54”
3= “35-44”
4= “18-34”.

Gender (IV)

1= “Male”
2= “Female”

Race (IV)

1= “Native Americans”
2= “Blacks or African Americans”
3= “All Others”
4= “Whites”

Education (IV)

1= “Primary” (<8 years)
2= “Secondary” (9-11years)
3= “College” (13-15years)
4= “Graduate” (16 and more)
5= “High School” (12years)

Marital status (IV)

1= “Divorced, widowed’’
2= “Separated”
3= “Now married”
4= “Never married’’

Employment (IV)

1= “Not in the labor force”
2= “Unemployed”
3= “Part-time”
4= “Full-time”

Health insurance coverage (IV)

0= “Uninsured”
1= “Insured”

Opioid abuse (DV)

0= “substance not reported”
1= “substance reported”

Treatment completion (DV)

0= “Treatment not completed”
1= “Treatment completed”
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Results
Research Question 1
Descriptive statistics for association sociodemographic factors and opioids
abusers
I performed descriptive statistics for sociodemographic factors, opioid abuse
(Other opiates/synthetics reported at admission), and treatment completion outcomes
(reason to group). The respondents' sociodemographic characteristics included age,
gender, race, education, employment status, and marital status. Data were summarized in
table 3, including frequency distribution and a percentage per category of each variable.
Males represented 59.9 % of the sample, while females made up 40.1 %. The sample was
made up of 49.1 % of high school level, followed by secondary (24.0%), college (20.3%),
primary (3.8%), and graduate (2.8%). Among respondents, 63.1 % represented "Never
married", followed by "Divorced, widowed" (21.5%), "now married" (14.1 %), and
"Separated" (1.4%). The sample was made up of 40.7% of unemployed, 31.6 % of fulltime workers, 16.3% of individuals not in the labor force, and 11.3% of part-time
workers. Regarding the age group frequency distribution, the sample comprised of 18-34
(52.1%), 35-44 (25.0%), 45-54 (17.2%), and 55 and older (5.7%). There were more
whites recorded in the sample accounting for 80.8%, Blacks or African Americans
(13.9%), All Others (0.4%), and Native Americans (4.9%). Among participants, 19.9 %
reported abusing opioids, while 80.1% did not report abusing opioids. Finally, 29.7% of
the sample completed treatment successfully.
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Table 3
Descriptive statistics demographic characteristics of sample
Variable
Education (IV)

Category
Primary
Secondary
High School
College
Graduate

Frequency (N)
782
4990
10229
4235
586

Percent (%)
3.8 %
24.0 %
49.1%
20.3%
2.8%

Marital Status (IV)

Never Married
Now married
Separated
Divorced, Widowed
Full-time
Part-time
Unemployed
Not in labor force
Male
Female
Native Americans
African Americans
Whites
All others
18-34
35-44
45-54
55 and older

13134
2928
284
4476
6590
2355
8479
3398
12474
8348
80
2897
16819
1026
10856
5200
3584
1182

63.1%
14.1%
1.4%
21.5%
31.6%
11.3%
40.7%
16.3%
59.9%
40.1%
0.4%
13.9%
80.8%
4.9%
52.1%
25.0%
17.2%
5.7%

14631
6191

70.3%
29.7%

Employment Status (IV)

Biologic sex (IV)
Race (IV)

Age (IV)

Treatment completion status Treatment not completed
(DV)
Treatment completed

Note. N=20822
Chi-square results for association between sociodemographic factors and
opioid abusers
Chi-square was conducted to assess whether sociodemographic factors were
associated with opioids abusers. The results from Chi-square for the association between
the selected sociodemographic factors (education, marital status, employment status,
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gender, race, and age) and opioids abusers were statistically significant for all of them
yielding a p-value < 0.05, with the effect size varying from small to medium.
The results from the analysis exhibited statistical significance between education
and opioids abusers with [Pearson χ2(4, N = 20822) = 18.028, p = 0.001, Cramer’s V=
0.029] (see tables 4 and table 5). Findings between marital status and opioids abusers
were statistically significant with [Pearson χ2 (3, N = 20822) = 38.540, p = 0.001,
Cramer’s V= 0.043] (see table 6 and 7). Besides, the association for employment status
revealed significance with [Pearson χ2 (3, N = 20822) = 51.717, p = 0.001, Cramer’s V=
0.050] (see table 8 and 9). Also, gender showed significance with [Pearson χ2 (1,
N=20822) =142.480, p=0.001, Cramer’s V=0.083] (see table 10 and 11). Furthermore,
the association with race yielded statistical significance too with [Pearson χ2 (3, N =
20822) = 492.672, p = 0.001, Cramer’s V= 0.154] (see table 12 and 13). Finally, it
demonstrated the relationship between age and opioids abuse was significant with
[Pearson χ2 (3, N = 20822) = 318.205, p = 0.001, Cramer’s V= 0.124] (see table 14 and
15).
Table 4
Chi-square results education vs. opioids abusers
Value

df

Asymptotic Significance (2-sided)

Pearson Chi-Square

18.028a

4

0.001

Likelihood Ratio

18.245

4

0.001

Linear-by-Linear
Association
N of Valid Cases

435

1

0.510

20822
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Table 5
Effect size for association education and opioids abusers
Value
Nominal by Nominal

Phi
Cramer’s V

Approximate
Significance
0.001
0.001

0.029
0.029

N of Valid Cases

20822

Table 6
Chi-square for association marital status vs. opioids abusers

Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases

Value
38.540a
38.092
24.908

df
3
3
1

Asymptotic Significance (2-sided)
0.000
0.000
0.000

20822

Table 7
Effect size for association marital status and opioids abuser
Nominal by Nominal

Phi
Cramer’s V

N of Valid Cases

Value
0.043
0.043

Approximate Significance
0.000
0.000

20822

Table 8
Chi-square for association between employment status and opioids abusers

Pearson Chi-Square

Value
51.717a

df
3

Likelihood Ratio

51.846

3

0.000

Linear-by-Linear
Association
N of Valid Cases

31.059

1

0.000

20822

Asymptotic Significance (2-sided)
0.000
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Table 9
Effect size for association marital status and opioids abusers
Value
Nominal by Nominal

Phi
Cramer’s V

Approximate Significance

0.050
0.050

N of Valid Cases

0.000
0.000

20822

Table 10
Chi-square for association between gender and opioids abusers
Value

Df

Asymptotic
Significance
(2-sided)

Pearson Chi-Square

142.480a

1

0.000

Continuity Correction b

142.058

1

0.000

Likelihood Ratio

140.663

1

0.000

Fisher’s Exact Test
Linear-by-Linear
Association

142.473

N of Valid Cases

20822

1

Exact Sig. (2sided)

Exact Sig. (1sided)

0.000

0.000

0.000

Table 11
Effect size for association between gender and opioids abusers
Value
Nominal by Nominal
Cramer’s V

N of Valid Cases

Phi

0.083
0.083

20822

Approximate Significance
0.000
0.000
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Table 12
Chi-square for association between race and opioids abusers
Value
Pearson Chi-Square

492.672

Likelihood Ratio

df

a

Asymptotic Significance

3

0.000

616.124

3

0.000

Linear-by-Linear
Association

235.528

1

0.000

N of Valid Cases

20822

Table 13
Effect size for association between race and opioids abusers
Value
Nominal by Nominal

Phi
Cramer’s V

N of Valid Cases

Approximate Significance

0.154
0.154

0.000
0.000

20822

Table 14
Chi-square for association between age and opioids abusers
Value
Pearson Chi-Square

318.205

Likelihood Ratio

a

df

Asymptotic Significance

3

0.000

350.593

3

0.000

Linear-by-Linear
Association

301.720

1

0.000

N of Valid Cases

20822
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Table 15
Effect size for association age and opioids abusers
Value
Nominal by Nominal

Phi
Cramer’s V

N of Valid Cases

0.124
0.124

Approximate Significance
0.000
0.000

20822

Multivariate logistic regression for association between sociodemographic
factors and opioids abusers
The researcher performed a multivariate logistic regression analysis to examine if
age, gender, race, education, marital status, and employment status predicted opioid
abuse (other opiates/synthetics). Recall that other opiates/synthetic comprised
buprenorphine, codeine, hydrocodone, hydromorphone, meperidine, morphine, opium,
oxycodone, pentazocine, propoxyphene, tramadol, and any other drug having morphinelike effects). In this analysis, the dependent variable of interest was opioid abuse (other
opiates/ synthetics). The predictor variables included education, marital status,
employment status, gender, race, and age. In this logistic regression model in table 16,
the reference groups for education, marital status, employment status, gender, race, and
age were high school, never married, full-time, female, whites, and age group 18-34,
respectively.
Education level: In the multivariate logistic regression (table 16), high school
educational level was used as the reference category. It was expected that having low
educational is more likely to abuse drug (Gul & Sharma, 2017).The results demonstrated
that only secondary and graduate levels were statistically significant. The results
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demonstrated that compared to high school level, secondary level was 1.2 times more
likely[OR=1.189, 95% CI (1.088, 1.299), p<0.0001] to abuse opioid; graduate level
was1.3 times more likely [OR = 1.269; 95% CI: .1.011, 1.592, p<0.05] to abuse opioids
in Indiana compared to high school level. However, the differences across group levels
showed no significance for primary education level (β = .121, S.E. = .096, Wald = 1.602,
p = .206), approaching significance for college level (β = .088, S.E. = .047, Wald =
3.499, p = .061), and significance for secondary level (β = .173, S.E. = .045, Wald =
14.662, p = .000), and graduate level (β = .238, S.E. = .116, Wald = 4.236, p =
.040).Therefore, secondary level and graduate level were associated with opioids abusers
in Indiana compared to high school level.
Marital status: The model considered ‘Never married’ as a reference category.
The results demonstrated statistical significance across all marital status categories. The
results demonstrated that those with ‘divorced, widowed’ marital status compared to
‘Never married’ were less likely to abuse opioids in Indiana [OR=0.809, 95% CI (0.741,
0.884), p<0.0001]. The ‘Separated’ marital status was less likely than ‘Never married’ to
abuse opioids [OR=0.621, 95% CI (0.460, 0.838), p<0.05]; ‘Now married’ marital status
was less likely than ‘Never married’ to abuse opioids [OR= 0.778, 95% CI (0.704,
0.860), p<0.0001]. Therefore, ‘Never married’ marital status or single was more likely to
abuse opioids compared to divorced/widowed, separated, and now married. Nonetheless,
the model (table 16) showed differences across marital status to be significant for all
group levels including divorced/widowed (β = -0.212, S.E. = .045, Wald = 21.851, p =
.000), separated (β = -0.476, S.E. = 0.153, Wald = 9.687, p = .002), and now married (β
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=-0.251, S.E. = 0.051, Wald = 23.990, p = .000). The results showed the odds ratio for
marital status to be <1 and a β negative across all marital status levels, suggesting that
there is a statistical difference between marital status and opioids abuse. Thus, the null
hypothesis is rejected, and that there is an association between marital status and opioids
abusers. Basically, single people were at highest risk compared to all other groups.
Employment status: In this group, full-time was used as the reference category.
The model showed statistical significance for ‘not in labor force’ and unemployed but did
not for part-timers. It showed that those in ‘not in labor force’ status was less likely than
full-timers to abuse opioids [OR=0.736, 95% CI (0.658, 0.822), p<0.0001] (see table 16).
Also, compared to full-timers, unemployed participants were less likely [OR= 0.749,
95% CI (0.688, 0.815), p<0.0001] to abuse opioids. Nevertheless, the outcomes indicated
differences across the group levels to be significant for ‘not in labor force’ (β = -0.307,
S.E. = .057, Wald = 29.067, p = .000), unemployed (β = -0.289, S.E. = .043, Wald =
44.969, p = .000), and non-significant for part-timers (β = -0.096, S.E. = 0.064, Wald =
2.211, p = .137). Thus, full-timers were more likely to abuse opioids in Indiana.
Gender: The model considered female as the reference category for gender. The
results demonstrated significance for male sex (see table 16). The results showed that
compared to female, male was 1.3 times more likely (OR=1.298, 95% CI (1.207,
1.395), p<0.0001) to abuse opioids. Also, the model showed a β positive (β=0.261, S.E. =
.043, Wald = 44.969, p = .000). Based on these outcomes, the null hypothesis is rejected.
Thus, there is an association between gender and opioids abusers and that female had a
lower risk of reporting opioids abuse in Indiana.
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Race: The reference category in this group is whites. The model suggested that
there was a statistical significance across all race categories. The results suggested that
compared to whites, Native Americans were 2.7 times more likely [OR=2.667, 95% CI
(1.220,5.831), p<0.05] to abuse opioid; Blacks or African Americans were 4.6 times
more likely [OR = 4.583; 95% CI (3.875, 5.421), p<0.0001]; All Others including
Asians, other single race, two or more races were 1.6 times more likely [OR=1.637, 95%
CI: 1.372, 1.953, p<0.0001] to abuse opioids in Indiana. It showed that whites had the
lower risk of reporting opioids abuse in Indiana. Additionally, the differences across
group levels showed statistical significance for all group levels including Native
Americans (β = .891, S.E. = .399, Wald = 6.045, p = .014), Blacks or African Americans
(β = 1.522, S.E. = .086, Wald = 315.768, p = .000), and All Others (β = .493, S.E. = .090,
Wald = 29.838, p = .000). The model demonstrated the odds ratio for race levels to be
greater than 1 and a β positive across all race categories. The null hypothesis is rejected;
thus, there is association between race and opioids abusers in Indiana and that whites
have lower risk of reporting opioids abuse.
Age: The reference category in this group is 18-34 years old. The outcomes
showed statistical significance for all categories. It showed that compared to age group
18-34, individuals aged 35-44 were 1.2 times more likely [OR=1.212,95%CI (1.114,
1.319), p<.0001]; 45-54 were 2.2 times more likely [OR=2.226, 95%CI (1.987, 2.495),
p<.0001]; age group 55 and older were 3.0 times more likely [OR=2.976, 95%CI (2.401,
3.690), p<.0001] to report opioids abuse in Indiana. The outcomes showed differences
across group levels to be statistically significant for 35-44 (β = .192, S.E. = .043, Wald =
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19.841, p = .000), 45-54 (β = .800, S.E. = .058, Wald = 189.558, p = .000), and 55 and
older (β = 1.091, S.E. = .0110, Wald = 99.057, p = .000).The null hypothesis is rejected;
therefore, there is an association between age and opioids abusers in Indiana. Younger
people have lower risk of reporting opioids abuse.
Table 16
Multivariate results for association sociodemographic factors and opioids abusers
Variables

B

S. E

Wald

df

Odds
ratio

95%
confidence
interval

Education
Primary
.121
.096 1.602
1
1.129 0.936-1.361
Secondary
.173
.045 14.662
1
1.189 1.088-1.299
College
.088
.047 3.499
1
1.092 0.996-1.198
Graduate
.238
.116 4.236
1
1.269 1.011-1.592
High school
----(reference)
Marital status
Divorced, widowed
-.212 .045 21.851
1
0.809 0.741-0.884
Separated
-.476 .153 9.687
1
0.621 0.460-0.838
Now married
-.251 .051 23.990
1
0.778 0.704-0.860
Never married (ref.)
----Employment status
Not in labor force
-.307 .057 29.067
1
0.736 0.658-0.822
Unemployed
-.289 .043 44.969
1
0.749 0.688-0.815
Part-time
-.096 .064 2.211
1
0.909 0.801-1.031
Full-time (ref.)
----Gender
Male
.261
.037 49.925
1
1.298 1.207-1.395
Female (ref.)
----Race
Native Americans
.891
.399 6.045
1
2.667 1.220-5.831
Blacks
1.522 .086 315.768 1
4.583 3.875-5.421
All others
.493
.090 29.838
1
1.637 1.372-1.953
Whites (ref.)
----Age
35-44
.192
.043 19.841
1
1.212 1.114-1.319
45-54
.800
.058 189.558 1
2.226 1.987-2.495
55 and older
1.091 .110 99.057
1
2.976 2.401-3.690
18-34 (ref.)
----Note: p=significance at 95% CI p >0.05, p<0.05*, p < 0.005**, p < 0.0001***

Significanc
ep

0.206
0.000***
0.061
0.040*

0.000***
0.002**
0.000***

0.000***
0.000***
0.137

0.000***

0.014*
0.000***
0.000***

0.000***
0.000***
0.000***
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Chi-square and multivariate logistic regression results for association
sociodemographic factors and treatment completion
Chi-square results for association sociodemographic and treatment completion
Chi-square tests were performed examine whether an association exists between
sociodemographic factors and opioids abusers. The results from Chi-square tests revealed
that the association between sociodemographic factors and treatment completion was
significant (p<0.05) for all of them except for race (p>0.05). Findings for education
demonstrated significance with [Pearson χ2 (4, N = 20822) = 45.690, p = 0.0001,
Cramer’s V= 0.047] (see tables 17 and table 18). Findings in tables 19 and 20 showed
significance for marital status with [Pearson χ2 (3, N = 20822) = 8.849, p = 0.031,
Cramer’s V= 0.021].
Also, employment status demonstrated the association to be statistically
significant with [Pearson χ2 (3, N = 20822) = 344.621, p = 0.0001, Cramer’s V= 0.129]
(see table 21 and table 22). The results from chi-square analysis revealed that
sociodemographic characteristics of gender was significant with [Pearson χ2 (1,
N=20822) =39.094, p=0.0001, Cramer’s V=0.043] (see table 23 and table 24). However,
race did not yield significance [Pearson χ2 (3, N = 20822) = 6.461, p = 0.091, Cramer’s
V= 0.018] (see table 25 and table 26). Finally, the chi-square analysis between age and
treatment completion status yielded statistical significance with [Pearson χ2 (3, N =
20822) = 64.777, p = 0.0001, Cramer’s V= 0.056] (see table 27 and table 28). Thus, these
findings showed that the sociodemographic factors were associated with treatment
completion using preliminary chi-square except for race.
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Table 17
Chi-square for association between education and treatment completion outcomes
Value
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases

45.690
45.294
41.926

df

a

Asymptotic Significance (2-sided)

4
4
1

0.000
0.000
0.000

20822

Table 18
Effect size for association education and treatment completion outcomes
Value
0.047
0.047

Nominal by Nominal
Phi
Cramer’s V
N of Valid Cases

Approximate Significance
0.000
0.000

20822

Table 19
Chi-Square results for association marital status and treatment completion outcomes
Value

df

a

Asymptotic Significance (2-sided)

3

0.031

Pearson Chi-Square

8.849

Likelihood Ratio

8.815

3

0.032

Linear-by-Linear
Association
N of Valid Cases

1.692

1

0.193

20822

Table 20
Effect size for association marital status and treatment completion outcomes
Value
Nominal by Nominal

N of Valid Cases

Phi
Cramer’s V

0.021
0.021
20822

Approximate Significance
0.031
0.031
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Table 21
Chi-square results for association employment status and treatment completion outcomes
Value
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases

344.621
339.458
320.722

df
a

Asymptotic Significance (2-sided)
3
3
1

0.000
0.000
0.000

20822

Table 22
Effect size for association employment status and treatment completion outcomes
Nominal by Nominal

Phi
Cramer’s V

Value
0.129
0.129

N of Valid Cases

Approximate Significance
0.000
0.000

20822

Table 23
Chi-square results for association gender and treatment completion outcomes

Pearson Chi-Square
Continuity Correction b
Likelihood Ratio
Fisher’s Exact Test
Linear-by-Linear
Association
N of Valid Cases

Value

Df

Asymptotic
Significance
(2-sided)

39.094a
38.901
39.323

1
1
1

0.000
0.000
0.000

39.093

1

0.000

Exact Sig. (2sided)

Exact Sig. (1sided)

0.000

0.000

20822

Table 24
Effect size for association gender and treatment completion outcomes
Nominal by Nominal

N of Valid Cases

Phi
Cramer’s V

Value
-0.043
0.043
20822

Approximate Significance
0.000
0.000
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Table 25
Chi-square results for association race and treatment completion outcomes

Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases

Value
6.461a
6.331
0.987

df
3
3
1

Asymptotic Significance (2-sided)
0.091
0.097
0.0321

20822

Table 26
Effect size for association race and treatment completion status
Nominal by Nominal

Phi
Cramer’s V

N of Valid Cases

Value
0.018
0.018

Approximate Significance
0.091
0.091

20822

Table 27
Chi-square results for association age and treatment completion outcomes
Value
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases

df

64.777a
62.230
47.389

3
3
1

Asymptotic Significance (2-sided)
0.000
0.000
0.000

20822

Table 28
Effect size for association age and treatment completion outcomes
Nominal by Nominal

N of Valid Cases

Phi
Cramer’s V

Value
0.056
0.056
20822

Approximate Significance
0.000
0.000
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Multivariate logistic regression results for association between
sociodemographic factors and treatment completion
The researcher applied a multivariate logistic regression analysis to examine the
association between sociodemographic factors (education, marital status, employment
status, gender, race, and age) and opioids abusers. The dependent or outcome variable
considered in this analysis was treatment completion status. The predictor variables
included education, marital status, employment status, gender, race, and age. The
multivariate logistic regression model in table 29 considered the reference category for
education, marital status, employment status, gender, race, and age as high school, never
married, full-time, female, whites, and age group 18-34, respectively.
Education: The baseline in this category is high school level. The model
suggested college and graduate level to be statistically significant. Whereas it did not
showed significance for primary and secondary levels. It showed that compared to high
school level, those with college level were 0.912 less likely [OR=0.912, 95% CI (1.219,
1.752), p<0.05]; individuals with graduate level were 0.731 less likely [OR=0.731, 95%
CI (0.614, 0.871), p<0.0001] to complete treatment. However, the model did not show
significance for primary and secondary levels. Additionally, differences across group
levels showed non-significance for primary (β = 0.151, S.E. = .087, Wald = 3.061, p =
.080), secondary (β = .066, S.E. = .039, Wald = 2.895, p = .089); significance for college
(β = -0.092, S.E. = .040, Wald = 5.222, p = .022) and graduate (β = -0.313, S.E. = .089,
Wald = 12.294, p = .000). The model demonstrated that the odds ratio for college and
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graduate had a significantly lower likelihood of treatment completion compared to high
school. Further research is needed to confirm or repudiate these findings.
Marital status: In this group, the reference category is ‘never married.’ The
outcomes suggested that only divorce/widowed marital status showed significance. It
demonstrated that compared to ‘never married’ marital status, those with
divorced/widowed status were 1.1more likely [OR=1.132, 95% CI (1.046, 1.225),
p<0.005] to complete treatment. However, it did not show significance for separated
[OR=0.978, 95% CI (0.754, 1.267), p<0.865] and for ‘now married’ [OR=0.997, 95% CI
(0.912, 1.089), p<0.943]. There is no association between marital status and treatment
completion.
Employment status: Full-time is considered the reference category in the model.
The results showed all categories to be statistically significant. It showed that compared
to full-timers, individuals in ‘not in labor force’ were 2.0 times more likely [OR=2.042,
95% CI (1.853, 2.252), p<0.0001], unemployed were 1.8 times more likely [OR=1.785,
95% CI (1.662, 1.916), p<0.0001], and part-timers were 1.4 times more likely
[OR=1.406, 95% CI (1.269, 1.557), p<0.0001] to complete treatment. It meant that fulltimers have lower treatment completion rate than ‘not in labor force’, unemployed, and
part-timers. Further, the differences across levels showed significance for ‘not in labor
force’ (β = 0.714, S.E. = .050, Wald = 205.935, p = .000), unemployed (β = .579, S.E. =
.036, Wald = 255.460, p = .000); part-timers (β = 0.341, S.E. = .052, Wald = 42.622, p =
.000). It showed the odds ratio across all categories to be >1 and a β positive. The null
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hypothesis is rejected; thus, there is an association between employment status and
treatment completion.
Gender: The reference category in gender group is female. The model showed
significance for male (table 29). It demonstrated that compared to females, males were
0.923 times less likely [OR=0.923, 95% CI (0.866, 0.983), p<0.05] and [β = -.081, S.E. =
.033, Wald = 6.108, p = .013] (see table 29). Thus, females had higher treatment
completion rate than males.
Race: The reference category chosen in this group is whites. The overall logistic
regression model showed that ‘All others’ were statistically significant (see table 29). It
showed that compared to whites, ‘All Others’ were 0.9 times less likely to complete
treatment with [OR=0.852, 95% CI (0.743, 0.976), p< 0.05] and [β = -.161, S.E. = .069,
Wald = 5.348, p = .021]. However, the results did not show significance for ‘Native
Americans’ [OR=0.822, 95% CI (0.515-1.312), p> 0.05] and for ‘Blacks or African
Americans’ [OR=1.049, 95% CI (0.960, 1.147), p>0.05]. Whites were more likely to
have higher treatment completion rate.
Age: The reference category for age is age group 18 to 34. The overall model
showed significance across all categories. It suggested that compared to age group 18-34,
individuals aged 35-44 were 0.517 times less likely [OR=0.517, 95% CI (0.452-0.591),
p<0.0001] with OR<1. Also, it showed that age group 45 to 54 were 0.833 times less
likely [OR=0.833, 95% CI (0.765-0.907), p<0.0001]; age group 55 and older were 0.918
times less likely [OR=0.918, 95% CI (0.851-0.990), p<0.05] to complete treatment
compared to 18 to 34. Likewise, the differences across the age group levels were
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significant for age group 35-44 (β = -0.086, S.E. = .039, Wald = 92.851, p = .000); age
group 45-54 (β = -0.183, S.E. = .043, Wald = 17.786, p = .000); and age group 55 and
older (β = -0.659, S.E. = .068, Wald = 4.919, p = .027). Therefore, the null hypothesis is
rejected, and I conclude that there is a negative association between age and treatment
completion. This suggested that younger people have higher treatment completion rate
than older people. That means, when you get older, it is less likely to complete treatment.
Table 29
Multivariate results for association between sociodemographic factors and treatment
completion outcomes
Variables

B

S. E

Wald

df

Odds
ratio

95% CI

Significance
p<0.05

Education
Primary
Secondary
College
Graduate
High school (reference)

.151
.066
-.092
-.313
----

.087
.039
.040
.089

3.061
2.895
5.222
12.294

1
1
1
1
--

1.163
1.069
0.912
0.731

0.982-1.378
0.990-1.154
0.843-0.987
0.614-0.871

0.080
0.089
0.022*
0.000***

Marital status
Divorced, widowed
..Separated
..Now married
..Never married (ref.)

.124
-.022
-.003
----

.040
.132
.045

9.432
0.029
0.005

1
1
1
--

1.132
0.978
0.997

1.046-1.225
0.754-1.267
0.912-1.089

0.002**
0.865
0.943

Employment status
..Not in labor force
..Unemployed
..Part-time
..Full-time (ref.)

.714
.579
.341
----

.050
.036
.052

205.935
255.460
42.622

1
1
1
--

2.042
1.785
1.406

1.853-2.252
1.662-1.916
1.269-1.557

0.000***
0.000***
0.000***

-.081
----

.033

6.108

1
--

0.923

0.866-0.983

0.013*

-.196
.048
-.161
----

.239
.046
.069

.676
1.113
5.348

1
1
1
--

0.822
1.049
0.852

0.515-1.312
0.960-1.147
0.743-0.976

0.411
0.292
0.021*

-.086
-.183
-.659
----

.039.0
43
.068

92.851
17.786
4.919

1
1
1
--

0.517
0.833
0.918

0.452-0.591
0.765-0.907
0.851-0.990

0.000***
0.000***
0.027*

Gender
Male
Female (ref.)
Race
Native Americans
Blacks
..All Others
..Whites (ref.)
Age
..35-44
45-54
..55 and older
..18-34 (ref.)

Note: p=significance at 95% CI p >0.05, p<0.05*, p < 0.005**, p < 0.0001***
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Research Question 2
Descriptive statistics for association health insurance vs. treatment completion
Descriptive statistics presented in table 28 for both variables (health insurance
coverage and treatment completion) revealed N= 20822 valid cases processed and zero
missing cases. The sample comprised of N=6926 individuals aged 18 and older who were
uninsured, accounting for 33.3%. While N= 13896 participants who were insured with
any insurance coverage, including private or government, representing 66.7% of the total
sample (Table 28). Among participants, there were a total of N=14631 who did not
complete their treatment accounting for 70.3%. There were dropped out of treatment,
terminated by the center, transferred to a new facility or program, incarcerated, or dead.
Those who did complete treatment successfully represented 29.7%.
Table 30
Descriptive statistics of health insurance coverage and treatment completion outcomes
Variables

Category

Frequency (N)

Percent (%)

Health Insurance coverage

Uninsured
Insured

6926
13896

33.3
66.7

Treatment Completion stat

Treatment not completed
Treatment completed

14631
6191

70.3
29.7

Note: N=20822
Chi-square of association between health insurance coverage and treatment
completion
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Table 31 showed that among individuals who did not complete treatment for
opioid abuse, the expected count for "uninsured" was 4866.7, while the observed count
was 4521. For those insured, the expected count was 9764.3, while the observed count
was 10110. Among individuals who completed the treatment for opioid abuse (treatment
completed), the expected count for "Uninsured" was 2059.3, and the observed count for
that same group was 2405. For the "Insured" group who did complete their treatment, the
expected count was estimated at 4131.7, and the observed count was 3786.
The chi-square test results were shown in table 32. The findings demonstrated the
association between health insurance coverage and successful treatment completion was
statistically significant with [Pearson χ2 (1, N = 20822) = 123.750, p = 0.0001, Cramer’s
V= 0.77)] (see table 32 and table 33). This outcome in table 32, with a p-value less than
0.05, indicated strong evidence against the null hypothesis. Therefore, the null hypothesis
was rejected, and the alternative hypothesis was accepted. This meant that there is an
association between health insurance coverage and treatment completion and that having
health insurance coverage predicted successful treatment completion. To understand the
extent of the association between health insurance coverage and treatment completion,
Cramer's V was run, and the result was presented in table 33. Cramer's V described the
association's effect size, and the table showed the value to be 0.77. Therefore, the effect
size of the association between health insurance coverage and treatment completion was
large enough for the generalization of the findings.
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Table 31
Crosstab between health insurance coverage and treatment completion outcomes
Health insurance status
Uninsured

Treatment Completion status

Treatment not completed Count
Expected Count
Treatment completed

Count

Total

4521

10110

14631

4866.

79764.3

14631.0

2405

3786

2059.3

4131.7

6191.0

Count

6926

13896

20822

Expected Count

6960.0

13896.0

Expected Count
Total

Insured

6191

20822.0

Table 32
Chi-square results for association between health insurance coverage and treatment
completion outcomes
Value

Df

Pearson Chi-Square

123.750a

1

Asymptotic
Significance
(2-sided)
.000

Continuity Correction b

123.392

1

.000

Likelihood Ratio

122.054

1

.000

Fisher’s Exact Test

Linear-by-Linear
Association

123.744

N of Valid Cases

20822

1

Exact Sig.
(2-sided)

Exact Sig.
(1-sided)

.000

.000
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Table 33
Effect size for association health insurance coverage and treatment completion outcomes
Value
Nominal by
Nominal

N of Valid
Cases

Phi
Cramer’s V

.077
.077

P
.000
.000

20822

Bivariate logistic regression
The inquirer ran a bivariate logistic regression to evaluate the association between
health insurance coverage and treatment completion (see table 34). It is expected that
having health insurance coverage (being insured) can have higher chance of treatment
completion (Feder et al., 2019).The reference category in this analysis was ‘Insured.’ The
outcomes of the analysis demonstrated statistical significance. It showed that compared to
insured, uninsured individuals were less likely [OR=0.704, 95% CI (0.662, 0.749),
p<0.0001] to complete treatment. The results also showed that (β =- 0.351, S.E. = .032,
Wald = 123.219, p = .000) [table 34]. That meant that compared to ‘Insured,’ people who
were uninsured (lacking insurance coverage) were 0.704 times (30%) less likely to
complete opioids treatment. The model demonstrated that the null hypothesis is rejected
and that having health insurance (being insured) is associated with treatment completion.
Thus, ‘Uninsured’ individuals have a lower chance of completing the treatment.
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Table 34
Bivariate results for association between health insurance coverage and treatment
completion outcomes
Variable

B

S. E

Wald

Uninsured

0.351

0.032 123.219

Insured (Ref)

-------

df

Odds
ratio

95% CI

1

0.704 0.662-0.749

P

0.000

-------

Research Question 3
Multivariate logistic regression between health insurance and treatment completion
outcomes after adjusting for sociodemographic factors
The investigator conducted a multivariate logistic regression to examine the
association between health insurance coverage and treatment completion after adjusting
for age, gender, race, marital status, employment status, and education (Table 35). The
outcome variable considered in this analysis was successful treatment completion. The
predictor variable in this multivariate logistic regression was health insurance with
sociodemographic factors adjusted. The investigator added education, marital status,
employment status, gender, race, and age to the model. The results suggested that
education was not associated with treatment completion. It did, however, showed
significance with college and graduate. It demonstrated that compared to high school
level, college were less likely [OR=0.915, 95% CI (0.846, 0.990), p<0.05], and graduate
less likely [OR=0.739, 95% CI (0.620, 0.881), p<0.05] since OR is less than 1.00.
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Besides, the outcomes revealed that marital status did not show significance. But it
showed that compared to single, divorced/widowed were 1.140 times more likely
[OR=1.140, 95% CI (1.053, 1.234), p<0.05] to complete treatment. Nonetheless, the
results demonstrated significance for employment status. It did show that compared to
full-timers, not in the labor force were 1.9 times more likely [OR=1.929, 95% CI (1.748,
2.128), p<0.0001]; unemployed were 1.8 times more likely [OR=1.801, 95% CI (1.677,
1.934), p<0.0001], and part-timers were 1.4 times more likely [OR=1.392, 95% CI
(1.256, 1.542), p<0.0001] to complete treatment. Findings revealed that gender was not
significant. Similarly, the results showed that race was not significant (p>0.05). It did
nonetheless showed significance for age across all levels. That meant, compared to age
group 18-34, age group 35 to 44 had lower likelihood [OR=0.509, 95% CI (0.445,
0.582), p<0.0001; age group 45 to 54 had lower likelihood [OR=0.826, 95% CI (0.759,
0.899), p<0.0001; and age group 55 and older had lower likelihood [OR=0.911, 95% CI
(0.845, 0.983), p<0.0001] to complete treatment since OR is less than 1.00. Most
importantly, the model showed that compared to insured, uninsured 0.722 times less
likely [OR=0.722, 95% CI (0.678, 0.770), p<0.0001] to complete treatment. It also
showed that after sociodemographic factors were adjusted, the OR increased from
[OR=704, 95% CI (0.662-0.749), p<0.0001] to [OR=0.722, 95% CI (0.678, 0.770),
p<0.0001]. I concluded an association exists between health insurance coverage and
treatment completion and that employment status and age were confounders. Though,
health insurance coverage is an independent factor that improves the chance of treatment
completion.

120
Table 35
Multivariate results for association health insurance coverage and treatment completion
outcomes after adjusting for sociodemographic factors
Variables

B

S. E

Wald

df

Odds
ratio

95%
confidence
interval

Significanc
e p<0.05

Health insurance
status
..Uninsured
Insured (Reference)

-.325
------

.033

99.701

1
--

0.722

0.678-0.770

0.000***

Education
Primary
Secondary
..College
..Graduate
..High school (ref.)

.150
.068
-.089
-.302
----

.087
.039
.040
.090

3.007
2.990
4.835
11.371

1
1
1
1
--

1.162
1.070
0.915
0.739

0.981-1.378
0.991-1.155
0.846-0.990
0.620-0.881

0.083
0.084
0.028*
0.001***

Marital status
..Divorced, widowed
..Separated
..Now married
..Never married (ref.)

.131
-.019
-.008
----

.040
.133
.045

10.502
0.020
0.030

1
1
1
--

1.140
0.982
0.992

1.053-1.234
0.757-1.273
0.908-1.084

0.001**
0.888
0.863

Employment status
..Not in labor force
..Unemployed
..Part-time
..Full-time (ref.)

.657
.588
.331
----

.050
.036
.052

171.441
261.582
39.910

1
1
1
--

1.929
1.801
1.392

1.748-2.128
1.677-1.934
1.256-1.542

0.000***
0.000***
0.000***

Gender
Male
Female (ref.)

-.049
----

.033

2.237

1
--

0.952

0.893-1.015

0.135

-.213
.061
-.148
----

.239
.046
.070

.795
1.778
4.472

1
1
1
--

0.808
1.063
0.863

0.506-1.291
0.972-1.162
0.753-0.989

0.373
0.182
0.034*

-.676
-.191
-.093
----

.069. 96.930
043 19.408
.039 5.789

1
1
1
--

0.509
0.826
0.911

0.445-0.582
0.759-0.899
0.845-0.983

0.000***
0.000***
0.016*

Race
Native Americans
Blacks
..All Others
..Whites (ref.)
Age
..35-44
45-54
55 and older
..18-34 (ref.)

Note: p=significance at 95% CI p >0.05, p<0.05*, p < 0.005**, p < 0.0001***
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Summary
This study design examined the association between sociodemographic factors
(i.e., age, gender, race, education, marital status, and employment status) and treatment
completion for opioids abusers in Indiana. The researcher applied descriptive statistics
such as frequency distribution to display data summary. The study further assessed the
association between health insurance coverage and treatment completion for opioid
abusers in Indiana after controlling for sociodemographic factors using chi-square and
logistic regression. A sample (N=20822) was used, accounting for 59.9% males and
40.1% females aged 18 and older. Almost half of the sample had a high school level
(49%), and slightly over 20% had a college degree or higher. Individuals who were never
married represented the sample's bulk (63%), and 22% were divorced/widowed.
Descriptive statistics showed that 41% of the sample were unemployed, while 32% had a
full-time job, and 11% had part-time employment. Most of the sample were Whites
(81%) and Blacks or African Americans (14%). Also, participants in the study were aged
18-34 years old (52%), 35-44 (25%), and 45-54 (17%).
Basic chi-square tests performed exhibited a statistically significant association
between sociodemographic factors and opioids abusers across all levels. The researcher
conducted a multivariate logistic regression analysis to assess the association between
sociodemographic characteristics and opioids abusers. The results demonstrated
statistical significance (p<0.05) for divorced or widowed/ separated/now married
compared to never married; male compared to female; Native Americans/ Blacks or
African Americans/ All Others compared to whites; older age group compared to

122
younger. Similarly, the outcomes revealed that never married were more likely to report
opioids abuse, and that being females, whites, and younger showed lower risk of
reporting opioids abuse in Indiana. Additionally, a multivariate logistic test for the
association between sociodemographic factors and treatment completion showed
significance (p<0.05) for not in labor force/unemployed/ part-timers compared to fulltimers; male compared to female; older age groups compared to younger age group (1834).The overall model revealed that being full-timers and younger is linked with lower
treatment completion rate. However, it demonstrated that being females is associated
with higher treatment completion rate. A bivariate model used to assess the association
between health insurance coverage and treatment completion status showed significance
and that being insured contributed to treatment completion outcome. After
sociodemographic attributes of education, marital status, employment status, gender,
race, and age were added to the model, health insurance coverage still showed
significance. It showed that employment status, and age might be confounders on the
association. The next section discussed interpretation of the results, limitations of the
study, recommendations, implications for positive social change, and conclusion.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
Substance abuse has been a longstanding health issue across the United Stated
(Gomes et al., 2018). In Indiana, in 2017, opioid abuse had claimed 1,700 lives due to
overdose Richard Fairbanks Foundation, 2018). Statistics showed individuals aged 18
and older were highly affected by substance abuse (NIDA, 2018). This study sought to
investigate the association between sociodemographic factors (i.e., age, gender, race,
marital status, employment status, and education level) and successful treatment
completion outcomes among opioid abusers in Indiana aged 18 and older using 2017
Treatment Episode Data Set Discharges (TEDS-D) that can be accessed through the CDC
WONDER. The current study also investigated the association between health insurance
coverage and treatment completion outcomes for opioids abusers in Indiana among
individuals aged 18 years and older. The study was conducted to advocate the expansion
of health insurance coverage for substance abuse patients (including opioids) and
improve treatment completion outcomes and access to care while reducing morbidity and
mortality due to opioid abuse among Indiana residents.
A sample size of N=20922 was used in this analysis. Descriptive statistics showed
that the sample was made up of 60% males and 40% females aged 18 and older. Data
summary demonstrated individuals with high school levels accounted for 49%, secondary
(24%), and those with college degrees accounted for slightly more than 24%. In this
sample, 63% were never married, 22% were divorced/widowed, and 14% were married.
Further, descriptive statistics revealed that 43% of the sample had a full-time or part-time
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job, while 41% were unemployed, 16% were not in labor force. The sample was made up
of Whites (81 %,) Blacks or African Americans (14 %,) Native Americans (slightly over
1 %,) and the rest represented "All others." Moreover, the sample showed that 30% did
report substance abuse. Additionally, there were 30% of individuals who did complete
treatment in the sample. Pearson chi-square between sociodemographic factors and
opioids abusers showed significance across all levels with a p-value less than 5%.
Nevertheless, basic Chi-square tests between the same sociodemographic attributes and
treatment completion showed statistical significance at all levels except for race.
Meaningful findings suggested a statistical significance correlation (p-value less
than 5%) between marital status, gender, race, age, and opioids abusers. The results
revealed that never married or single were more likely to report opioids abuse while
females, whites, and younger people had a lower risk of reporting opioids abuse in
Indiana. Similarly, the outcomes showed the association between employment status,
gender, age, and treatment completion to be statistically significant. It demonstrated that
females had a higher treatment completion rate, whereas full-timers and younger people
had a lower treatment completion rate. Furthermore, the association between health
insurance coverage and treatment completion was significant, and that uninsured
individual had a lower chance of completing treatment. It suggested that marital status,
employment status, and age were confounders in the association. The next sections will
discuss the interpretation of my findings, the study's limitations, recommendations,
implications for positive social change, and conclusion.
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Interpretation of the Findings
This research fills the gaps by assessing the association between the selected
sociodemographic factors and treatment completion status for opioids abusers. Also, it
sought to evaluate the correlation between health insurance coverage and treatment
completion status after sociodemographic factors were adjusted.
Research Question 1: Sociodemographic factors and treatment completion for
opioids abuse
The findings were statistically significant for secondary and graduate levels. The
outcomes approached significance for college level. That meant, compared to high
school, secondary level was 1.2 times more likely [OR=1.189, 95% CI (1.088,
1.299), p<0.0001]; graduate-level was 1.3 times more likely [OR = 1.269; 95% CI:
.1.011, 1.592, p<0.05] to abuse opioids. It demonstrated that when people are more
educated, they are more likely to engage in substance abuse. These findings were
different from studies by Gomes et al. (2018); Gul & Sharna., 2017; and Swendsen et al.,
2009), which showed that education was strongly associated with substance abuse.
Concerning marital status, findings revealed that those with 'divorced, widowed'
marital status were less likely to abuse opioids compared to 'never married.' Similarly,
'Separated' marital status was less likely than 'Never married' to abuse opioids; 'Now
married' marital status was less likely than 'Never married' to abuse opioids. Therefore,
'Never married' marital status was more likely to abuse opioids than divorced/widowed,
separated, and now married. The results showed the odds ratio for marital status
suggested an association between marital status and opioids abusers. This study's results

126
were consistent findings from Lamptey (2005); and Tavares et al.(2004). Other studies
found single or never married to be a predictor of opioid abuse (Ray et al., 2017; and
Swendsen et al., 2009). It could be that long-term opioid abusers are less likely to find
spouses; thus, they are more likely to stay single, and some never get to marry. However,
further research is needed to confirm these findings.
The results demonstrated that employment status was statistically significant
across ‘not in labor force’ and unemployed, but non-significant for part-timers. It was
assumed that the more people hold full-time employment, the less likely they engage in
substance abuse activities. But the outcomes revealed that compared to full-timers,
individuals in ‘not in labor force’ were less likely to report opioids abuse. Similarly, the
results suggested that unemployed people were less likely than full-timers to abuse
opioids. The outcomes represented a reversal that found full-time employment to have
protective effects against drug problems (Simoni-Wastila& Strickler, 2011). However, in
a previous study by Simoni-Wastila& Strickler (2011), the investigators did not find fulltime and part-time employment status to be associated with opioids abuse. Besides,
Henkel (2011) and Tavares et al. (2004) demonstrated unemployment to be a significant
risk factor for substance abuse and dependence. Henkel (2011) further elaborated that
unemployment can augment the risk of relapse after drug addiction treatment. More
investigation is needed to understand the variations for sociodemographic employment
status.
The current study results found that males have a higher risk of reporting opioids
abuse than females, with a ratio of 1.3. Previous studies also had reported that being male
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had a greater likelihood than female to abuse opioids (Gomes et al., 2018; Lamptey,
2005; Ray et al.,2017; and Wisniewski et al. (2008). However, McCabe et al. (2017))
findings were contradictory and found that females had a higher risk of abusing opioids
than male individuals. Another survey did not find any difference with gender (Swendsen
et al., 2009). More study is needed to validate the current results.
Moreover, the results showed significance for all racial levels (p<0.05).
Compared to whites, Native Americans were 2.7 times more likely to abuse opioids; It
demonstrated that Blacks or African compared to whites were 4.6 times more likely to
report opioids abuse. Compared to ‘All Others’ including Asians, other single race, two
or more races were 1.6 times more likely to abuse opioids in Indiana. It showed that
whites have a lower risk of reporting opioids abuse in Indiana. Other studies found that
white people were more likely to abuse opioids (Lamptey, 2005; Ray et al., 2011;
Simoni-Wastila& Strickler). However, other studies did not find any difference.
Furthermore, sociodemographic characteristic of age was significantly correlated
with opioid abuse in this study. The outcomes revealed that compared to the age group
18-34, individuals aged 35-44 were 1.2 times more likely to report opioids abuse. Age
groups 45-54 were 2.2 times more likely to report opioids abuse than individuals aged
18-34. Also, people aged 55 and older were 3.0 times more likely to report opioids abuse
compared to the age group 18-34. These findings were consistent with the results from
the surveys conducted by Ray et al. (2011) and Simoni-Wastila& Strickler (2011). On the
other hand, some surveys revealed that drug abuse was more prevalent in adolescents
(Gomes et al., 2018; Kolodny et al., 2015; McHugh et al.,2014; Ranjan et al., 2010 and
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Wisniewski et al., 2008) and in younger people (Lamptey, 2005; Swendsen et al., 2009
and Tavares et al., 2004). Nonetheless, more investigation is needed to confirm these
findings.
The association between the selected sociodemographic factors and treatment
completion status had been assessed (see table 29). Findings revealed that college and
graduate-level were statistically significant. However, the results showed nonsignificance for primary and secondary levels. It meant that compared to the high school
level, individuals with college-level were 0.912 more likely to complete treatment.
Similarly, individuals with graduate-level were 0.731 more likely to complete treatment.
However, the model did not show significance for primary and secondary levels. This
study's results aligned with previous findings from Newton-Howes & Stanley (2015).
Also, surveys suggested that failure to complete treatment was positively associated with
lower educational attainment (Brown, 2010; Knight et al., 2009). There is a need for
more investigation to validate the results of this study.
Regarding marital status, the outcomes suggested that only individuals with
divorce/widowed marital status were significant. It demonstrated that compared to 'never
married' marital status, individuals having divorced/widowed status were 1.1 more likely
to complete treatment. Separated and now married were more likely to complete
treatment than never married or single, but these differences were not significant.
Previous studies found different outcomes and that Whites were more likely to complete
treatment (76.7%). More research is needed to confirm these results.
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Besides, the results of this study yielded a statistical significance for employment
status across all levels. It showed that compared to full-timers, individuals in 'not in labor
force' were 2.0 times more likely to complete treatment; Unemployed were 1.8 times
more likely, and part-timers were 1.4 times more to complete treatment when compared
to full-timers. This could be related to lack of social support. Some studies found no
difference between employment status and treatment completion (Bazargan-Hejazi et al.,
2016 and Suntai et al., 2020), and another found unemployed to be predictive of
treatment completion (Brown, 2010). Further research is needed.
Moreover, the results demonstrated that males were 0.923 times less likely to
complete treatment than their counterparts' females. This meant that females have a
higher treatment completion rate than males. The results were consistent with previous
research conducted by Guerrero et al. (2014). On the contrary, other studies found that
males had higher treatment completion rates than females (Bazargan-Hejazi et al., 2016;
and Suntai et al., 2020). It is common to believe that women were more likely to receive
services that match their needs than men. Nonetheless, Brown's (2020) survey did not
find any difference between gender and treatment completion.
The outcomes of the study showed race not to be statistically significant. It does,
however, showed significance for the ‘All Others’ race group. It meant that compared to
whites, ‘All Others’ (Asians, other single race, and two or more races) were 0.918 times
less likely to complete treatment. Other findings from Suntai et al. (2020) revealed that
Blacks were less likely than whites to complete treatment. However, the study conducted
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by Brown (2010) found non-white ethnicity to be strongly correlated with treatment
completion outcomes compared to whites.
Finally, the results of the study demonstrated age to be statistically significant at
all levels. It showed that compared to age group 18-34, individuals aged 35-44 were
0.517 times less likely to complete treatment. Also, age groups 45 to 54 were 0.833 times
less likely than age group 18-34 to complete treatment. Compared to age group 18-34,
individuals aged 55 and older were 0.918 times less likely to complete treatment. The
overall results demonstrated that younger people have a higher treatment completion rate
than older people since the OR for all level was less 1.00. Further research could help
figure out the reasons for this shift. Evidence suggested that older people would have
better treatment outcomes than younger. Because as reported in a survey, older people do
not face system-level barriers for treatment since they generally possessed public
insurance coverage through Medicare, Tricare, and VA (Choi et al., 2014). The outcomes
in this study showed that younger had higher treatment completion rates compared to
older people. Previous research recognized some barriers that led to similar findings. It
had been shown that substance abuse treatment barriers for older people included lack of
readiness to discontinue use and lack of knowledge about services, treatment, and
programs (Choi et al., 2014). Conversely, Choi et al. (2014) noted that younger people
faced substance abuse treatment barriers such as cost, stigma, and confidentiality
concerns. The study outcomes could be due to education. Tackling the epidemic of
opioids has been one of the main focuses of public health policymakers in Indiana;
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Education is the primary focus to help individuals understand the health consequences of
opioid abuse (Indiana State Department of Health, 2018).
On the other hand, this study outcome were different from Suntai et al. (2020,)
whose findings suggested that older people have higher treatment completion rates for
substance abuse. Although older adults had higher odds of substance abuse treatment
completion, the multivariate logistic regression model suggested differences among racial
groups (Suntai et al., 2020). The study noted that Black older adults had a lower
likelihood of completing substance use treatment than their White counterparts [OR=
0.630]. It showed that the difference had deepened between whites and Blacks subjects,
with Blacks older adults being 34% less likely to complete treatment than Whites (Suntai
et al., 2020).
Research Question 2: Association of Health insurance and treatment completion
The study outcomes showed significance for health insurance coverage. It demonstrated
that compared to insured, uninsured individuals were 0.704 times less likely to complete
treatment. These study findings showed that ‘Uninsured’ individuals have a lower chance
of completing the treatment than insured individuals. Previous studies found an
association between health insurance coverage and successful treatment completion
(Allcock et al., 2019; Mojtabai et al., 2020 and Olfson et al., 2018;). Research conducted
by Mojtabai et al. (2020) reported that numerous privately insured adults with drug use
disorders in the United States were not covered for drug use treatment. However, the
article suggested that the Affordable Care Act's enaction introduced new benefits to cover
individuals with substance use problems (Mojtabai et al., 2020). When assessed the
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correlation between having drug use treatment coverage and receiving treatment,
Mojtabai et al. (2020) found that coverage was statistically significantly correlated with
receiving treatment [OR= 2.09, 95% CI = 1.61–2.72, p < .001]. Additionally, the
investigators examined such association in two simulated situations with participants who
ignored their coverage (in one scenario, none of the participants had coverage and, the
second scenario assumed that all participants had coverage.) The outcomes revealed that
the association of drug treatment coverage with actual receipt of treatment was
statistically significant in both scenarios yielding [OR = 2.46, 95% CI = 1.91–3.16, p <
.001] and [OR = 1.46, 95% CI = 1.14–1.88, p = .004], respectively (Mojtabai et al.,
2020). Olfson et al. (2019) found a significant increase in private insurance use among
individuals aged 19-25 (8%) and 26-35 years old (1.2%) between 2008-2010 and 20112013. But the increase within the two groups did not differ between 2011-2013 to 20142016 with 3.2% and 3.8%, respectively. Also, a research conducted by Allcock et al.
(2020) found that health insurance was strongly associated with both outpatient and
inpatient care [OR: 1.28; 95% CI: 1.08–1.52; p = 0.005] and [OR: 1.52; 95% CI: 1.26–
1.82; p < 0.001]. However, the studies' results noted the utilization of health insurance
coverage to be low (Allcock et al., 2019; Motjabai et al., 2020 and Olfson et al., 2018).
Also, the more health insurance coverage people have the better chance of
completing treatment for substance abuse. Having health insurance coverage is a strong
predictor of drug treatment completion. Cummings et al. (2014) assessed the association
between private insurance coverage for substance use disorders and specialty treatment
among U.S. Adults. The analysis outcomes indicated that privately insured individuals
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who did not know their coverage status for drug dependence had a lower likelihood of
receiving drug treatment from specialty services compared to the uninsured (Cummings
et al., 2014). However, Cummings et al. (2014) found alcohol addiction strongly
correlated with private insurance use (Cummings et al., 2014). Evidence suggested that
many adults remained without health insurance coverage (Allcock et al., 2019;
Cummings et al., 2014; Mojtabai et al., 2020; Olfson et al., 2018). According to
Cummings et al. (2014), about 25% of adults with alcohol dependence, and 34% of them
with drug dependence without insurance coverage. But Choi et al. (2020) noted that older
adults were usually covered through Medicare. Health insurance coverage is vital for
substance users and expanding health insurance coverage to these populations can help
improve their overall health outcomes. The expansion of coverage through the
implementation of the Affordable Care Act (ACA) could well achieve this objective
(Cummings et al., 2014; Huhn et al., 2020; Mojtabai et al., 2020).
Research Question 3: Health insurance coverage versus treatment completion
after controlling for sociodemographic factors.
After sociodemographic factors were adjusted, the results still demonstrated
significance between health insurance coverage and treatment completion among
participants in this study. The results showed that compared to insured, uninsured 0.733
times less likely [OR=0.733, 95% CI (0.688, 0.781), p<0.0001] to complete treatment.
After sociodemographic factors were adjusted, the OR increased from [OR=704] to
[OR=0.733]. I concluded an association between health insurance coverage and treatment
completion and that employment status and age were confounders on the association.
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Limitations of the study
Despite its contribution noted above, the present secondary data analysis and
cross-sectional study might have several limitations to be considered. Firstly, data about
drug use treatment and coverage were self-reported. This could lead to recall and social
desirability biases. Although evidence that TEDS-D datasets have high reliability and
validity, it is possible that some respondents might report misleading responses. Drugs
are also considered a societal issue and collecting accurate information from individuals
dealing with drug use might be challenging. Inaccurate answers to the primary research
questions could lead to bias, so it is essential to comprehend the dataset's accuracy being
analyzed (Boo & Froelicher, 2013). There was potential for information and selection
biases. Cummings et al. (2014) noted that health insurance status is self-reported, and the
comprehensiveness of insurance coverage for drug treatment could not be corroborated.
Another survey suggested that insurance coverage for substance use treatment depends
on the type of services provided at the treatment settings. Understanding insurance
coverage for drug abuse can lead a person to seek drug use treatment (Mojtabai et al.,
2020). Further, the available datasets did not reveal information related to factors that can
influence treatment completion, like existing community resources such as social support
(Bazargan-Hejazi et al., 2016). It is imperative to assess the association of insurance
coverage with these treatment characteristics in future research.
Secondly, the datasets were derived from submissions by individual programs that
received funding from the States. This can hinder data quality collection because
agencies receiving less funding might not be able to target and treat many individuals

135
with substance abuse issues as possible. Suntai et al. (2020) noted that only state-funded
treatment program outcomes were submitted, which could exclude private treatment
programs, private jails, and other programs such as Alcoholics Anonymous (AA). Stahler
& Menni (2020) noted that there might be variation in data quality and the way treatment
completion was determined at the program level. Therefore, funding restriction might
lead to the State's ability to only focus its efforts on the populations at their reach, leaving
out many substance abusers without coverage. The available dataset in this study was
based on admissions, not individuals. Many survey entries might have been reported as
admissions for the same patient instead of the client itself. This could influence the
overall outcomes as well as their reliability and validity.
Third, non-responsive and missing information might tilt the direction of the
survey and might impact the results. The national TEDS contained many missing values.
However, in the final analysis of the extracted Indiana datasets, a simple random sample
method had been employed. All missing values were removed during the analysis to
minimize the impact of missing values and increase the study outcomes' reliability and
validity. Consequently, this study's reliability could be similar to the TEDS-D national
survey on substance abuse.
Lastly, the study's cross-sectional nature represents a limitation because data were
collected at one specific point in time, and the causality of the association cannot be
established. The use of public and de-identified datasets represents a limitation in this
study. Evidence showed that the major threats to the reliability and validity of secondary
data analysis derived from the approaches used during the initial data collection (Boo &
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Froelicher, 2013). Issues may arise from the sampling method used, data collection, nonresponse, and missing data. Because the researcher did not participate in the initial
research design and data collection and because of the nature of this study, the causality
of the association between sociodemographic factors and treatment completion as well as
the association between health insurance and treatment completion could not fully be
assessed (Allcock et al., 2019). It has been demonstrated that the main threats to the
reliability and validity of secondary data analysis derived from the accuracy of the
approaches used during the primary data collection. However, adequate measures were
taken, including sampling strategy and handling of missing data had been employed to
minimize potential bias during the analytic phase of this study.
Recommendations
Based on the outcomes of this research, the investigator had formulated various
recommendations. First, a statewide longitudinal survey on the association between
sociodemographic attributes and treatment completion for opioids abuse should be
conducted to recognize the most predictor attributes and develop policies to address the
problem. Additionally, a statewide longitudinal survey should be conducted to investigate
the association between health insurance coverage and treatment completion for opioids
abuse. The state should also enact strict laws to control opioids misuse through medical
prescriptions and enforce them rigorously. The state should promote population-based
education to increase awareness among those most affected. Interdisciplinary efforts
should be fostered by involving all sectors to tackle the ongoing opioids abuse in Indiana
and its health consequences, including overdose.
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Further, the state must expand health insurance coverage for individuals without
coverage for opioids specialty treatment entry through the Affordable Care Act advocacy
to improve treatment retention and completion. The federal government must allocate
enough funding for states to address this deadly public health issue. The study
recommends all healthcare professionals (e.g., physicians, nurses, counselors, and
emergency responders) know how to respond to overdose crises to reduce mortality rates.
Simultaneously, the integration of substance abuse screening at primary care settings
should be among doctors' and nurses' priorities to recognize early signs and initiate
referral procedures for immediate care or interventions. Finally, the association of health
insurance coverage with treatment completion and the relationship between
sociodemographic and opioids abuse need to be explored further to better address this
public health issue in the state of Indiana.
Positive social change implications
The study's findings suggested that most of the selected sociodemographic factors
(e.g., education, marital status, employment status, gender, race, age) were predictors of
opioids abuse in Indiana. Targeting these factors through various intervention plans,
including a screening at primary care settings and population-based education, could
promote positive social change in Indiana. Special attention should be given to males,
minorities, single, full-timers, and older people. Simultaneously, understanding predictors
for treatment completion and emphasizing more on full-timers, males, minorities, older
people who experienced lower treatment completion rates compared to younger could
help develop strategies to improve opioids treatment completion and retention in Indiana.
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Also, strengthening and strictly enforcing the existing policies related to opioids
prescriptions help promote positive social change in the communities. The study
demonstrated that having health insurance coverage was an independent predictor of
treatment completion. Hence, expanding insurance health insurance coverage among
target populations through Medicaid, Medicare, private, or employers might help
improve entry to opioids specialty treatment and promote positive social change among
those most affected. Health insurance could be scaled-up through community
engagement approaches that employ the media and other advocacy tools.
Conclusion
Opioid abuse remains a pressing public health issue in Indiana. The study
suggested marital status, gender, race, and age were the most predictors of opioids abuse
in Indiana. It further demonstrated that employment status, gender, and age were most
likely to predict successful treatment completion. Finally, people with health insurance
coverage had a higher chance of completing treatment than uninsured even after
sociodemographic factors were adjusted. Implementing more screening of individuals at
risk, promoting population-based education, advocating for health insurance coverage,
and enforcing the existing policies vigorously could promote positive social change
among the affected communities in Indiana.
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Appendix A: List of Abbreviations
ADOM: Alcohol and DRUG Outcome Measure
AUD: Alcohol use disorder
DALY disability-adjusted life-years
DAWN: Drug Abuse Warning Network
CDC: Centers for Disease Control and Prevention
ISDH: Indiana State Department of Health
YLL: Years of life lost
MC: Marion County
MOUD: Medication for Opioid Use Disorder
MTF: Monitoring the Future
NHAMCS: National Hospital Ambulatory Medical Care Survey
NSDUH: National Survey on Drug Use and Health
NIDA: National Institute on Drug Abuse
NUPO: Nonmedical use of prescription opioids
OPA: Opioid prescription abuse
OPR: Opioid pain reliever
OUD: Opioid use disorder
SCT: Social cognitive theory
UNODC: United Nations Office on Drugs and Crime or UNODC
WHO: World Health Organization
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Your IRB approval number is 11-17-20-0721940
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Appendix C: SPSS Outputs
Education
Cumulative
Frequency
Valid

Primary

Percent

Valid Percent

Percent

782

3.8

3.8

3.8

Secondary

4990

24.0

24.0

27.7

College

4235

20.3

20.3

48.1

586

2.8

2.8

50.9

High School

10229

49.1

49.1

100.0

Total

20822

100.0

100.0

Graduate

Marital status
Cumulative
Frequency
Valid

Divorced, widowed

Percent

Valid Percent

Percent

4476

21.5

21.5

21.5

284

1.4

1.4

22.9

Now married

2928

14.1

14.1

36.9

Never married

13134

63.1

63.1

100.0

Total

20822

100.0

100.0

Separated

EMPLOY group
Cumulative
Frequency
Valid

Percent

Valid Percent

Percent

Not in labor force

3398

16.3

16.3

16.3

Unemployed

8479

40.7

40.7

57.0

Part-time

2355

11.3

11.3

68.4

Full-time

6590

31.6

31.6

100.0

20822

100.0

100.0

Total

Biologic sex
Cumulative
Frequency
Valid

Male
Female
Total

Percent

Valid Percent

Percent

12474

59.9

59.9

59.9

8348

40.1

40.1

100.0

20822

100.0

100.0

Race to group
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Cumulative
Frequency
Valid

Native Americans

Percent

Valid Percent

Percent

80

.4

.4

.4

Blacks or African Americans

2897

13.9

13.9

14.3

All Others

1026

4.9

4.9

19.2

Whites

16819

80.8

80.8

100.0

Total

20822

100.0

100.0

AGE Group
Cumulative
Frequency
Valid

Percent

Valid Percent

Percent

55 and older

1182

5.7

5.7

5.7

45-54

3584

17.2

17.2

22.9

35-44

5200

25.0

25.0

47.9

18-34

10856

52.1

52.1

100.0

Total

20822

100.0

100.0

Health to group
Cumulative
Frequency
Valid

Uninsured

Percent

Valid Percent

Percent

6926

33.3

33.3

33.3

Insured

13896

66.7

66.7

100.0

Total

20822

100.0

100.0

Other opiates/synthetics reported at admission
Cumulative
Frequency
Valid

Substance not reported
Substance reported
Total

Percent

Valid Percent

Percent

16686

80.1

80.1

80.1

4136

19.9

19.9

100.0

20822

100.0

100.0

Reason to group
Cumulative
Frequency
Valid

Treatment not completed
Treatment completed
Total

Percent

Valid Percent

Percent

14631

70.3

70.3

70.3

6191

29.7

29.7

100.0

20822

100.0

100.0
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Case Processing Summary
Cases
Valid
N
Other opiates/synthetics

Missing

Percent

N

Total

Percent

N

Percent

20822

100.0%

0

0.0%

20822

100.0%

20822

100.0%

0

0.0%

20822

100.0%

20822

100.0%

0

0.0%

20822

100.0%

20822

100.0%

0

0.0%

20822

100.0%

20822

100.0%

0

0.0%

20822

100.0%

20822

100.0%

0

0.0%

20822

100.0%

reported at admission *
Education
Other opiates/synthetics
reported at admission *
Marital status
Other opiates/synthetics
reported at admission *
EMPLOY group
Other opiates/synthetics
reported at admission *
Biologic sex
Other opiates/synthetics
reported at admission *
Race to group
Other opiates/synthetics
reported at admission *
AGE Group

Chi-Square Tests
Asymptotic
Significance (2Value

df

sided)

a

4

.001

Likelihood Ratio

18.245

4

.001

Linear-by-Linear Association

11.821

1

.001

N of Valid Cases

20822

Pearson Chi-Square

18.028
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a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is
116.40.

Symmetric Measures
Approximate
Value
Nominal by Nominal

Significance

Phi

.029

.001

Cramer's V

.029

.001

N of Valid Cases

20822

Crosstab
Marital status
Divorced, Separa
widowed
Other

Substance not

Count

opiates/synthetics reported

Expected

reported at

Count

admission

Substance

Count

reported

Expected

ted

Now

Never

married

married

3501

222

2267

10696 16686

3586.9

227.6

2346.4

10525.1 16686
.0

975

62

661

2438

4136

889.1

56.4

581.6

2608.9

4136.

Count
Total

0

Count
Expected

4476

284

2928

13134 20822

4476.0

284.0

2928.0

13134.0 20822

Count

.0

Chi-Square Tests
Asymptotic
Significance (2Value

df

sided)

38.540a

3

.000

Likelihood Ratio

38.092

3

.000

Linear-by-Linear Association

24.908

1

.000

N of Valid Cases

20822

Pearson Chi-Square

Total

163
a. 0 cells (0.0%) have expected count less than 5. The minimum
expected count is 56.41.

Symmetric Measures
Approximate
Value
Nominal by Nominal

Significance

Phi

.043

.000

Cramer's V

.043

.000

N of Valid Cases

20822

Crosstab
EMPLOY group

Other

Substance not

Count

opiates/synthetics

reported

Expected

reported at
admission

Not in labor

Unemploy

Part-

Full-

force

ed

time

time

2716

6610

1926

5434

16686

2723.0

6794.8

1887.2

5281.0

16686.

Count
Substance

Count

reported

Expected

Total

0
682

1869

429

1156

4136

675.0

1684.2

467.8

1309.0

4136.0

3398

8479

2355

6590

20822

3398.0

8479.0

2355.0

6590.0

20822.

Count
Total

Count
Expected
Count

0

Chi-Square Tests
Asymptotic
Significance (2Value

df

sided)

51.717a

3

.000

Likelihood Ratio

51.846

3

.000

Linear-by-Linear Association

31.059

1

.000

N of Valid Cases

20822

Pearson Chi-Square
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a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is
467.79.

Symmetric Measures
Approximate
Value
Nominal by Nominal

Significance

Phi

.050

.000

Cramer's V

.050

.000

N of Valid Cases

20822

Crosstab
Biologic sex
Male
Other opiates/synthetics

Substance not reported

reported at admission
Substance reported

Total

Count

10333

6353

16686

Expected Count

9996.2

6689.8

16686.0

2141

1995

4136

Expected Count

2477.8

1658.2

4136.0

Count

12474

8348

20822

12474.0

8348.0

20822.0

Count

Total

Female

Expected Count

Chi-Square Tests
Asymptotic

Value
Pearson Chi-Square
Continuity Correction
Likelihood Ratio

b

df

Significance (2-

Exact Sig. (2-

Exact Sig. (1-

sided)

sided)

sided)

142.480a

1

.000

142.058

1

.000

140.663

1

.000

Fisher's Exact Test
Linear-by-Linear

.000
142.473

Association
N of Valid Cases

20822

1

.000

.000
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a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 1658.21.
b. Computed only for a 2x2 table

Crosstab
Race to group
Blacks or
Native

African

Americans Americans
Other

Substance not

opiates/synthetics

reported

Count
Expected

reported at
admission

73

2743

64.1

2321.6

All
Others

Whites

Total

872

12998

16686

822.2 13478. 16686.

Count
Substance

Count

reported

Expected

154

1

0

3821

4136

7

154

15.9

575.4

203.8 3340.9 4136.0

80

2897

1026

80.0

2897.0

Count
Total

Count
Expected
Count

Asymptotic
Significance (2df

sided)

492.672a

3

.000

Likelihood Ratio

616.124

3

.000

Linear-by-Linear Association

485.341

1

.000

Pearson Chi-Square

N of Valid Cases

20822

a. 0 cells (0.0%) have expected count less than 5. The minimum
expected count is 15.89.

Symmetric Measures

20822

1026.0 16819. 20822.
0

Chi-Square Tests

Value

16819

0
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Approximate
Value
Nominal by Nominal

Significance

Phi

.154

.000

Cramer's V

.154

.000

N of Valid Cases

20822

Crosstab
AGE Group
55 and
older

45-54

Total

Substance not

Count

1076

8312

16686

opiates/synthetics

reported

Expected

947.2 2872.1 4167.1 8699.6

16686.

admission

4141

18-34

Other

reported at

3157

35-44

Count

0

Substance

Count

106

reported

Expected

427

1059

2544

4136

234.8

711.9 1032.9 2156.4

4136.0

1182

3584

10856

20822

1182.0 3584.0 5200.0 10856.

20822.

0

0

Count
Total

Count
Expected
Count

Chi-Square Tests

Asymptotic
Significance (2Value

df

sided)

a

3

.000

Likelihood Ratio

350.593

3

.000

Linear-by-Linear Association

301.720

1

.000

Pearson Chi-Square

N of Valid Cases

318.205

20822

5200
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a. 0 cells (0.0%) have expected count less than 5. The minimum expected
count is 234.79.

Symmetric Measures

Approximate
Value
Nominal by Nominal

Significance

Phi

.124

.000

Cramer's V

.124

.000

N of Valid Cases

20822

95% Confidence
Interval for Exp(B)
Std.
Reason to groupa
Treatment not

B
Intercept

Error

.982

Wald

df

.019 2657.3

completed

Sig.

Exp(B)

Lower

Upper

Bound

Bound

1

.000

1

.000

.704

.662

.749

0

.

.

.

.

89
[Health to

-.351

.032 123.21

group=0]
[Health to
group=1]

9
b

0

.

.
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Case Processing Summary

N
Reason to group

Health to group

Education

Treatment not completed

Marginal Percentage
14631

70.3%

Treatment completed

6191

29.7%

Uninsured

6926

33.3%

Insured

13896

66.7%

Primary

782

3.8%

Secondary

4990

24.0%

College

4235

20.3%

586

2.8%

10229

49.1%

4476

21.5%

284

1.4%

Now married

2928

14.1%

Never married

13134

63.1%

Not in labor force

3398

16.3%

Unemployed

8479

40.7%

Part-time

2355

11.3%

Full-time

6590

31.6%

12474

59.9%

8348

40.1%

80

0.4%

Blacks or African Americans

2897

13.9%

All Others

1026

4.9%

16819

80.8%

55 and older

1182

5.7%

45-54

3584

17.2%

35-44

5200

25.0%

18-34

10856

52.1%

20822

100.0%

Graduate
High School
Marital status

Divorced, widowed
Separated

EMPLOY group

Biologic sex

Male
Female

Race to group

Native Americans

Whites
AGE Group

Valid
Missing

0

Total

20822

Subpopulation

1878a

a. The dependent variable has only one value observed in 930 (49.5%) subpopulations.
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Parameter Estimates
95% Confidence Interval
for Exp(B)
Std.
Reason to groupa
Treatment not

B
Intercept

Error

.712

Wald

.043

completed

df

277.11

Sig.

Exp(B)

1

.000

Lower

Upper

Bound

Bound

6
[Health to

-.325

.033

99.701

1

.000

.722

.678

.770

0b

.

.

0

.

.

.

.

[Education=1]

.150

.087

3.007

1

.083

1.162

.981

1.378

[Education=2]

.068

.039

2.990

1

.084

1.070

.991

1.155

[Education=3]

-.089

.040

4.835

1

.028

.915

.846

.990

[Education=4]

-.302

.090

11.371

1

.001

.739

.620

.881

[Education=5]

0b

.

.

0

.

.

.

.

.131

.040

10.502

1

.001

1.140

1.053

1.234

-.019

.133

.020

1

.888

.982

.757

1.273

-.008

.045

.030

1

.863

.992

.908

1.084

0b

.

.

0

.

.

.

.

.657

.050

171.44

1

.000

1.929

1.748

2.128

1

.000

1.801

1.677

1.934

group=0]
[Health to
group=1]

[Marital
status=1]
[Marital
status=2]
[Marital
status=3]
[Marital
status=4]
[EMPLOY
group=1]
[EMPLOY

1
.588

.036

group=2]
[EMPLOY

261.58
2

.331

.052

39.910

1

.000

1.392

1.256

1.542

0b

.

.

0

.

.

.

.

[Biologic sex=1]

-.049

.033

2.237

1

.135

.952

.893

1.015

[Biologic sex=2]

b

.

.

0

.

.

.

.

group=3]
[EMPLOY
group=4]

0
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[Race to

-.213

.239

.795

1

.373

.808

.506

1.291

.061

.046

1.778

1

.182

1.063

.972

1.162

-.148

.070

4.472

1

.034

.863

.753

.989

0b

.

.

0

.

.

.

.

[AGE Group=1]

-.676

.069

96.930

1

.000

.509

.445

.582

[AGE Group=2]

-.191

.043

19.408

1

.000

.826

.759

.899

[AGE Group=3]

-.093

.039

5.789

1

.016

.911

.845

.983

[AGE Group=4]

b

.

.

0

.

.

.

.

group=1]
[Race to
group=2]
[Race to
group=3]
[Race to
group=4]

0

a. The reference category is: Treatment completed.
b. This parameter is set to zero because it is redundant.

